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SUMMARY 
The process that balances the X-chromosome monosomy in male Drosophila flies is known 
as dosage compensation. Dosage compensation results in a twofold increase in transcription 
of X-chromosomal genes mediated by a complex known as the male-specific-lethal dosage 
compensation complex (MSL-DCC) that regulates gene expression at the step of 
transcriptional elongation. Appropriate levels of MSL-DCC and hence of the protein subunits 
it consists of - MSL1, MSL2, MSL3, MOF and MLE - are essential for male viability. 
Recently, the male-specific MSL2 protein was discovered to bear E3 ubiquitin ligase activity 
enabling auto-ubiquitylation as well as ubiquitylation of the other MSL-DCC subunits. 
Ubiquitylation most likely contributes to maintaining complex homeostasis through 
proteasomal degradation. However, some ubiquitin marks may also serve to modulate the 
molecular interactions or activity of MSL proteins. The MSL-DCC subunit MOF is a 
prominent substrate for MSL2. MOF is a histone acetyltransferase that catalyzes acetylation 
of histone H4 at lysine 16, a hallmark of the dosage-compensated male X chromosome. 
The present study provides the first comprehensive analysis of MOF ubiquitylation. Results 
from in vitro ubiquitylation assays indicate that MSL2 preferentially modifies N-terminal 
lysine residues in MOF. However, using a mass spectrometry-based approach a different 
ubiquitylation pattern was observed on both endogenous MOF and tagged derivatives 
expressed in cell lines. To analyze the functions MOF ubiquitylation in more detail and to 
distinguish potential MSL2-dependent from MSL2-independent MOF ubiquitylation, mutated 
MOF proteins, in which relevant lysines were changed to arginines (K>R) were characterized 
both in vitro and in vivo using recombinant protein, stable cell lines and transgenic flies, 
respectively. 
Most of the K>R mutations of MOF exhibited only mild effects on MSL-DCC association 
and male viability, suggesting that lack of ubiquitylation or any other modification of these 
lysines are either dispensable or otherwise buffered by the biological system. Only the 
mutation of 9 lysines in the C-terminal half of MOF (MOF-9KC) had an effect as expression 
of this mutant in vivo resulted in impaired X-territorial targeting, MSL-DCC association and 
male viability. However, these defects are most likely unrelated to ubiquitylation but rather 
result from impaired complex association due to lack of interaction with the scaffold protein 
MSL1. MSL2-dependent MOF ubiquitylation could not be detected in vivo in the context of 
abundant ubiquitylation of MOF catalyzed by other E3 ligases, both in the nucleus and 
cytoplasm. 
Earlier work from the group had indicated that MSL2 also targets proteins outside the MSL-
DCC. Of particular interest was the H3-H4 histone chaperone and elongation factor SPT6. To 
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enable future investigations of the involvement of SPT6 in dosage compensation and MSL2-
dependent ubiquitylation, a toolkit consisting of recombinant SPT6 and monoclonal 
antibodies directed against SPT6 was established. First assays demonstrated that MSL2 
extensively ubiquitylates SPT6 in vitro. 
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ZUSAMMENFASSUNG 
Männliche Vertreter der Fruchtfliege Drosophila melanogaster weisen durch die 
Anwesenheit eines einzelnen männlichen X Chromosoms eine Monosomie auf, die durch den 
Prozess der Dosiskompensation an das Niveau der zwei weiblichen X Chromosomen 
angepasst wird. Dazu wird die Genexpression X-chromosomaler Gene durch den sogenannten 
Dosiskompensationskomplex (MSL-DCC) selektiv in Männchen verdoppelt, ein Prozess der 
auf Ebene der transkriptionellen Elongation gesteuert wird. 
Das korrekte Verhältnis der einzelnen Komplexproteine - MSL1, MSL2, MSL3, MOF und 
MLE - ist hierbei unabdingbar für die Lebensfähigkeit der männlichen Fruchtfliege. Erst 
kürzlich konnte nachgewiesen werden, dass MSL2 eine E3 Ubiquitin Ligase ist, welche sich 
selbst und andere Untereinheiten des Dosiskompensationskomplexes durch Ubiquitylierung 
modifiziert. In diesem Zusammenhang trägt die Ubiquitylierung durch die Vermittlung 
proteasomaler Abbauprozesse zur Aufrechterhaltung der korrekten Komplexhomöostase bei. 
Abgesehen von Degradationsprozessen, beeinflussen Ubiquitylierungen auch molekulare 
Interaktionen oder modulieren die Aktivität der MSL-DCC Proteine. So ist die 
Komplexuntereinheit MOF als prominentes Substrat für MSL2-vermittelte Ubiquitylierungen 
bekannt. MOF ist eine Histon Acetyltransferase, die den Transfer einer Acetylgruppe auf das 
Lysin 16 des Histonproteins 4 katalysiert, eine Modifikation, die das dosiskompensierte 
männliche X Chromosom charakterisiert. 
Die vorliegende Arbeit liefert eine umfassende Untersuchung und Charakterisierung der MOF 
Ubiquitylierung. Ergebnisse aus in vitro Ubiquitylierungsreaktionen konnten zeigen, dass 
MSL2 vorzugsweise Lysinseitenketten im Bereich des MOF N-terminus modifiziert. Im 
Gegensatz dazu wurde mittels massenspektrometrischer Untersuchungen ein anderes 
Ubiquitylierungsmuster an endogenem bzw. transgenem MOF aus entsprechenden Zelllinien 
nachgewiesen. Um die Funktionen der MOF Ubiquitylierung im Detail zu untersuchen, sowie 
potentielle MSL2-abhängige und -unabhängige Ubiquitylierungsprozesse voneinander 
abzugrenzen, wurden MOF Mutanten generiert, in denen relevante Lysinreste (K) durch 
Argininreste (R) ausgetauscht wurden. Mittels rekombinanter Proteine, stabiler Zellinien und 
transgener Fliegenstämme wurden die generierten K>R MOF Mutanten sowohl in vitro als 
auch in vivo charakterisiert. Dabei zeigte sich, dass die meisten der integrierten K>R MOF 
Mutationen lediglich geringe Effekte auf die Komplex-Assoziation und die Lebensfähigkeit 
männlicher Fliegen hatten. Diese Beobachtung impliziert, dass das Fehlen von 
Ubiquitylierung oder anderer Modifikationen an den entsprechenden Lysinresten entweder 
nur unwesentlichen Einfluss hat oder anderweitig durch das biologische Umfeld ausgeglichen 
wird. Lediglich die Mutation von insgesamt 9 Lysinresten im Bereich des MOF C-terminus 
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(MOF-9KC) zeichnete sich in vivo durch einen Verlust der X-territorialen Lokalisation, 
Komplexassoziation, sowie reduzierter Lebensfähigkeit männlicher Fliegen aus. Vermutlich 
beruhen diese Einschränkungen jedoch nicht auf dem Fehlen entsprechender 
Ubiquitylierungen, sondern resultieren aus der mangelnden Interaktion von MOF-9KC mit 
dem Gerüstprotein MSL1. Letztendlich erschwerte ubiquityliertes MOF, das vermutlich nicht 
durch MSL2 sondern eine Vielzahl anderer E3 Ligasen modifiziert wurde und reichlich in 
Nukleus und Zytoplasma vorhanden ist, den Nachweis MSL2-abhängiger MOF 
Ubiquitylierung in vivo. 
Frühere Studien innerhalb der Arbeitsgruppe deuteten bereits darauf hin, dass MSL2 auch 
Proteine außerhalb des MSL-DCC modifiziert. Von besonderem Interesse war hierbei SPT6, 
ein H3-H4 Chaperon und Elongationsfaktor. Um zukünftige Untersuchungen bezüglich der 
Beteiligung von SPT6 im Zusammenhang mit der Dosiskompensation und MSL2-anhängiger 
Ubiquitylierung zu ermöglichen, wurden sowohl rekombinantes SPT6 also auch 
entsprechende monoklonale Antikörper generiert. Erste Untersuchungen in vitro ergaben, 
dass MSL2 in der Lage ist, SPT6 in erheblichem Maße zu ubiquitylieren.  
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1.1 Chromatin 
Almost 60 years have passed from the discovery of DNA as the carrier of genetic information 
(Avery, Macleod and McCarty, 1944) to the determination of the human DNA sequence by 
the international human genome project (HGP) at the beginning of the 21th century. Fast it 
became clear that the sole information about the genome sequence provided more questions 
than answers. Multi-cellular organisms comprise many different cell types. Still, all of them 
exhibit the same genetic information stored within their nuclei. The realization of this “blue 
print” into cellular processes such as differential gene expression relies on a highly dynamic 
environment to allow for responses to endogenous and exogenous stimuli. Nature has 
developed highly efficient tools to ensure proper gene expression at the right time and place 
throughout the lifetime of an organism. Distinct molecular factors but also genome 
organization and chromatin play major roles when it comes to fine-tuning mechanisms and 
modulation of gene expression.  
 
1.1.1 Chromatin structure and organization 
Eukaryotic cells store their large genomes in a highly organized manner as DNA-protein 
complex within their nuclei. Already at the end of the nineteenth century Flemming observed 
that some nuclear structures heavily absorb a basic dye, thus naming these structures 
“chromatin”, from the Greek word for color. It took almost another 100 years to the discovery 
of nucleosomes as the structural and functional unit of chromatin. The basic unit of each 
nucleosome is represented by the nucleosome core particle (Kornberg, 1974; Dekker and 
Oudet, 1975) that consists of 147 bp of superhelical, left-handed, negatively charged DNA 
wrapped in 1.65 turns around a positively charged histone octamer (Figure 1). Multiple 
protein-protein interactions between the single histones but also electrostatic and hydrogen 
bonds between DNA and histone proteins stabilize the nucleosome structure (Rohs, 2009; 
Davey, 2002). The canonical histone-octamer is composed of two H3-H4 and two H2A-H2B 
histone dimers (Luger, 1997; Richmond and Davey, 2003). 
Two structurally and functionally distinct domains can be assigned to the small and basic 
histone proteins: a core and a tail. The core resembles the structured and globular domain of 
the histones, facing the inner part of the nucleosome unit. In contrast to the histone core, the 
largely unstructured and flexible C- and N-terminal tails face the surface of the nucleosome 
representing the accessible part of chromatin. Fifteen to 38 amino acids from the basic and 
unstructured N-terminal tails of the histones serve as modules for posttranslational 
modifications such as methylation, phosphorylation, acetylation and ubiquitylation.  
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Figure 1: Structure of the nucleosome core particle, viewed in two orientations. First published in 
Luger, 1997, the scheme shows both the view down the super-helical axis (left) as well as a rotation of 
the nucleosome core particle rotated by 90° around the vertical axis (right). The 2.8 Å high-resolution 
crystal structure displays the wrapping of DNA (light blue) around the octamer of histones (blue: H3; 
green: H4; yellow: H2A; red: H2B) in 1.65 left-handed helical turns. Histone tails and extensions 
reaching out of the structure are displayed in white. [Adapted and reprinted with permission from 
Elsevier (Luger, 2003; Current Opinion in Genetics & Development).]  
 
The nucleosome composition can be varied both through the incorporation of non-canonical 
histone variants and the attachment of posttranslational modifications to the flexible histone 
tails. In contrast to canonical histones that are expressed only during S-phase (Marzluff, 
2002), non-canonical histones are expressed throughout the cell cycle (Loyola and Almouzni 
2007). Encoded by distinct genes non-canonical histones are non-allelic isoforms of canonical 
histones that differ in their sequences and expression patterns. Except for histone H4, all other 
histones have several histone variants. In humans for example, almost 20 different histone 
variants have been described so far. Replacement of the canonical histones by histone variants 
is facilitated independently of the cell cycle by specialized replication-independent enzymes 
such as remodeling enzymes or chaperones. The replacement of canonical histones by histone 
variants can be used to label the state of chromatin or mark specialized genome regions. In 
line with this human H2A.Z or the Drosophila H2A.V, respectively were shown to be 
phosphorylated after DNA double strand breaks thus triggering the recruitment of DNA repair 
processes (Thiriet, 2005). 
Electron microscopy studies have visualized nucleosomes that line up on a DNA stretch as 
“beads-on-a-string” (Benbow, 1992), able to generate a fiber with a diameter of 11 nm and 
resulting in a ~5-fold condensation of the underlying DNA. This first layer of packaging is 
further compacted by the association with histone H1 to the 10-80 bp linker DNA bridging 
two nucleosomes and allowing the formation of the 30 nm fiber (Thoma and Koller, 1977; 
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Adkins, 2004) that subsequently fold into higher order chromatin structures like interphase or 
mitotic chromosomes. To date the existence of the 30 nm fiber is a matter of constant debate 
and most data that demonstrate the existence of the 30 nm fiber were obtained in vitro. Using 
electron microscopy isolated nucleosome fibers were observed to form structures with a 
diameter of roughly 30 nm in vitro (Finch and Klug, 1976). Moreover, it was proposed that 
nucleosomal arrays and H1-chromatin form 30 nm fibers only under very specific ionic 
conditions in vitro (Maeshima, 2016). However, the evidence for the 30 nm fiber in vivo is 
rather limited as all attempts to visualize the fibers failed so far (Eltsov, 2008; Maeshima, 
2010; Fussner, 2011). Currently it is assumed that there are no regular chromatin structures 
present in vivo beyond the 10 nm fiber (Joti, 2012; Nishino, 2012). In fact a recent model 
suggests the presence of irregularly folded nucleosome fibers that give rise to the higher order 
chromatin organization present in interphase nuclei (Belmont and Bruce, 1994) or mitotic 
chromosomes (Rattner and Lin, 1985). Furthermore, it was proposed that once the H4 tail 
promotes folding and oligomerization of the 10 nm fiber it can no longer engage the 
interaction with the acidic patch of neighboring nucleosomes in order to adopt the 30 nm fiber 
(Maeshima, 2016; Figure 2). 
 
Figure 2: Chromatin structure according to the old and new view. A molecule of DNA with a 
diameter of ~2 nm is wrapped around a histone octamer forming a nucleosome fiber of ~10 nm. 
According to the old model the nucleosome was assumed to fold into 30 nm chromatin fibers (left) and 
subsequently into higher organization of interphase nuclei or mitotic chromosomes, respectively. 
Depicted on the right is the novel hypothesis of irregularly folded fibers [Adapted and reprinted with 
permission from Springer (Maeshima, 2014; Chromosoma]. 
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1.1.2 Histone modifications 
Chromatin features and organization affect gene transcription in various ways as the 
compaction status of chromatin determines the accessibility of DNA. Two major mechanisms 
are crucial for alteration of chromatin structure: (1) chromatin remodeling complexes that 
affect the interaction between histones and DNA in an ATP-dependent manner (Längst, 2015; 
Jin, 2005); and (2) attachment of posttranslational modifications (PTMs) to the N-terminal 
histone tails, and to a lesser extent also within the C-terminal tails and globular domains of 
histones (Kouzarides, 2007; Jack and Hake, 2014). For example acetylation of histone H4 at 
lysine 16 (H4K16ac) directly affects chromatin structure as it is suggested to prevent 
formation of the 30 nm fiber (Robinson, 2008; Shogren-Knaak, 2006). Consequently, 
transcription is substantially derepressed after targeting of H4K16ac to promoters in vitro and 
in vivo (Akhtar and Becker, 2000). On the other hand placement of histone modifications by 
chromatin modifying enzymes indirectly affect chromatin structure in a way that they provide 
binding platforms for the recruitment of specific effector proteins that locally act on 
chromatin organization (Fischle, 2008). 
The placement of post translational modifications to the flexible histone tails is facilitated by 
a multitude of highly specific histone-modifying enzymes and their recruitment to chromatin 
is triggered by diverse factors such as DNA-binding factors, co-activators and repressors, 
RNA polymerase II (RNAPII) or preceding histone modifications (Luger, 2012). PTMs of 
histone tails such as phosphorylation, methylation, ubiquitylation and acetylation are major 
regulators of chromatin structure as those histone marks affect inter-nucleosomal interactions. 
Hence, histone modifications are involved in regulation of DNA accessibility as well as the 
manipulation and expression of DNA in various cellular processes (Zentner and Henikoff, 
2013). 
Phosphorylation of histone tails is a highly dynamic process resulting from the addition and 
removal of phosphate groups by kinases and phosphatases, respectively. The transfer of a 
phosphate group from ATP to the hydroxyl group of an amino-acid side chain predominantly 
occurs on serines, threonines and tyrosines. Placement of a phosphate group onto histone tails 
introduces a negative charge that significantly influences chromatin structure. In contrast, the 
attachment of methyl groups to arginines and lysines does not alter the charge of the histone 
protein. Methylation of target protein is carried out by methyltransferases that catalyze the 
transfer of a methyl group from S-adenosylmethionine (SAM) to the ω-guanidino group of 
arginine or the ε-amino group of lysine, respectively (Struck, 2012). Methylation of histones 
adds a layer of complexity as arginines may be mono-, symmetrically or asymmetrically di-
methylated, whereas lysines may be mono-, di- or tri-methylated (Torres and Fujimori, 2015). 
In the past methylation of histones was considered to be a rather stable and static histone 
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modification. However, in 2004 the first lysine demethylase was identified (Shi, 2004) thus 
providing a tight regulation of histone methylation by the concise action of methylases and 
demethylases. While phosphorylation and methylation of histones result in relatively small 
molecular changes on the amino-side chains, ubiquitylation on the other hand introduces a 
much larger covalent modification and changes histone mass to a higher extent. The 
attachment of the 76 aa ubiquitin polypeptide to lysines occurs in different degrees (mono-, 
di-, multi-, poly-ubiquitylated). However, on histones mono-ubiquitylation seems to be the 
most relevant modification (Bannister and Kouzarides, 2011). Histone mono-ubiquitylation is 
mainly found on histones H2A and H2B and is not involved in proteasomal targeting but 
rather affects nucleosomal dynamics (Meas and Mao, 2015). 
Posttranslational modification of histones and histone acetylation in particular was first 
documented in the early 1960s (Phillips, 1963; Allfrey, 1964). Since then the involvement of 
histone acetylation in the regulation of transcription and gene expression has been studied 
extensively. In fact, the transfer of an acetyl group from acetyl-Coenzyme A to the ε-amino 
group of lysines neutralizes the positive charge of lysine side chains. Consequently, the 
interactions between histones and nucleosomal DNA are weakened leading to increased DNA 
accessibility for the transcription machinery (Dion, 2005). On the other hand, histone 
acetylation changes binding properties of effector proteins (eg. PHD/ bromodomain proteins) 
which in turn regulate gene expression through the recruitment of chromatin remodelers 
(Bannister and Kouzarides, 2011). 
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1.1.3 Histone acetyltransferases 
Chromatin-dependent processes such as transcriptional regulation, DNA repair and chromatin 
accessibility are tightly coupled to histone modification states. Histone acetylation was one of 
the first described histone modifications, yet it took several decades to unravel the biological 
functions of histone acetylation and histone modifications in general. The covalent acetylation 
of lysine residues is a highly dynamic process regulated by antagonizing histone-modifying 
enzymes: histone acetyltransferases (HATs) and deacetylases (HDACs; Figure 3). Both 
enzymes are found at sites of active transcription (Wang, 2009). 
 
 
Figure 3: Histone acetylation is maintained by the opposing activities of histone acetyl 
transferases (HATs) and deacetylases (HDAC). HATs transfer the high-energy acetyl moiety from 
acetyl Coenzyme A (Ac-CoA) to the respective ε-amino group of a respective lysine residue of the 
histone N-tail. HDACs catalyze the reversal reaction.  
 
HATs have been identified in eukaryotic organisms from yeast to human and can be grouped 
in at least four different families based on the structural homology within their respective 
HAT domains (Marmorstein and Roth, 2001; Wang, 2008): p300/CBP, Rtt109, Gcn5/PCAF 
and MYST. While p300/CBP (named for the two human paralogs p300 and CBP) is 
metazoan-specific, Rtt109 (named for its initial identification as a regulator of Ty1 
transposition gene product 109) is fungal-specific, Gcn5/PCAF (named for its founding 
member yeast Gcn5 and its human ortholog, PCAF) and MYST families have homologues 
from yeast to human. The MYST (named for the founding members MOZ, Ybf2/ Sas3, Sas2 
and Tip60) represents the largest family of HATs (Marmorstein and Trievel, 2009) and will 
be discussed hereafter in more detail. 
The defining feature of MYST histone acetyltransferases is the presence of the highly 
conserved MYST (HAT) domain that comprises the acetyl-CoA binding site (Figure 4). 
Furthermore, most MYST domains are characterized by the presence of a C2HC zinc finger 
1 INTRODUCTION 
12 
(Yang, 2004). In dMOF the C2HC zinc finger is crucial for both HAT activity and 
nucleosome binding in vitro (Akhtar and Becker, 2001). The lysine residue at position K274 
of the human MOF protein sequence is a highly conserved autoacetylated residue, relevant for 
conformational changes, substrate induced binding and HAT activity on H4K16 (Yuan, 
2012). 
 
hMOF 
ySas2 
dMOF 
hMOZ 
hTip60 
ySas3 
                   * 
259 YCQNLCLLAKLFLDHKTLYFDVEPFVFYILTEVDRQGA(0)HIVGYFSKEKESPDGNNVACILTLPPYQRRG 328 
153 FCQCLCLFTKLYLDNKSMYFKVDHYEFYIVYETGSTKP(0)..MGFFSKDLVSYQQNNLACILIFPPYQRRG 220 
590 YCQLLCLMAKLFLDHKVLYFDMDPFLFYILCETDKEGS(0)HIVGYFSKEKKSLENYNVACILVLPPHQRKG 659 
589 YCQNLCLLAKLFLDHKTLYYDVEPFLFYVLTQNDVKGC(0)HLVGYFSKEKHCQQKYNVSCIMILPQYQRKG 658 
312 YSQNLCLLAKCFLDHKTLYYDTDPFLFYVMTEYDCKGF(0)HIVGYFSKEKESTEDYNVACILTLPPYQRRG 381 
352 YSQNLCLLAKCFINSKTLYYDVEPFIFYILTEREDTEN(9)HFVGYFSKEKFSNNDYNLSCILTLPIYQRKG 430 
 
Figure 4: Sequence alignment of the active site residues of selected MYST protein members. The 
conserved autoacetylated lysine residue is indicated with an asterisk. Sequence similarity is encoded by 
background color: identical aa = dark gray, similar aa = light gray, different aa = white.  
 
MYST proteins structurally resemble each other in many ways still they are involved in the 
regulation of various biological processes from DNA repair and cell cycle progression to 
epigenetic and transcriptional control (Yuan, 2012). Some of the MYST family members 
share additional structural features such as chromodomains and plant homeodomain-linked 
(PHD) zinc fingers. Domain organization and structural features of selected MYST proteins 
from S.cerevisiae, Drosophila and human are depicted in Figure 5. 
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Figure 5: Domain organization and structural features of MYST proteins. Schematic representation 
of MYST proteins from S. cerevisiae (Esa1, essential Sas2-related acetyltransferase 1; Sas2, something 
about silencing 2; Sas3, something about silencing 3), D. melanogaster (dTip60, HIV Tat interacting 60 
kDa protein; dMOF, male-absent on the first; CHM, Chameau; CG1894, uncharacterized MYST protein) 
and human (hTip60; hMOF; HBO1, HAT bound to ORC1, a Chameau ortholog). CBD, chromobarrel 
domain; Ser, serine-rich domain; CH, cysteine/histidine-rich domain; C2HC, zinc finger; NEMM, N-
terminal part of Enok, MOZ or MORF; PHD, PHD zinc finger. Numbers at the end of each structure 
correspond to the total protein residues. Figure adapted from Yang, 2004.  
 
1.1.4 Histone chaperones 
Synthesis and assembly of canonical histones mainly happens during DNA replication, 
whereas expression and incorporation of histone variants into chromatin also happens outside 
of S-phase. However, both canonical histones and histone variants are highly dependent on 
histone chaperones. Histone chaperones associate with histones and regulate nucleosome 
assembly in an ATP-dependent manner (Avvakumov, 2011; Gurard-Levin, 2014). All histone 
chaperones share a fundamental property: they promote the transfer of histones to naked 
DNA in vitro to reconstitute nucleosomes (De Koning, 2007). However, in vivo not all 
histone chaperones necessarily promote nucleosome assembly, instead they are involved in 
DNA repair and transcription (Jeronimo and Robert, 2016). 
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The classification into H3-H4 or H2A-H2B histone chaperones is based on the selectivity for 
respective histone proteins, yet it is not fully strict. This is mainly due to the fact that some 
histone chaperones also exhibit affinity for different histone proteins in addition (Gurard-
Levin, 2014). Moreover, many histone chaperones are characterized by the presence of an 
acidic patch that is suggested in neutralizing the basic nature of histone proteins 
(Belotserkovskaya, 2003; Park and Luger, 2006). But also PTMs are capable in changing the 
electrostatic properties of histone chaperones thus directly affecting histone binding 
(Regnard, 2000). 
SPT6 is an essential and highly conserved histone H3-H4 chaperone and transcription 
elongation factor suggested to restore nucleosomes in the wake of RNAPII transcription 
(Dronamraju and Strahl, 2014). In Drosophila the 1831 aa SPT6 was demonstrated to 
positively stimulate the elongation rate of RNAPII in vivo (Ardehali, 2009). The N-terminus 
of SPT6 features a highly conserved and acidic region harboring multiple negatively charged 
amino acids (Figure 6) essential for the binding of positively charged histone molecules and 
the histone chaperone activity of SPT6. A region rich in certain amino acids such as serine, 
threonine, and glycine characterizes the C-terminus of SPT6. There are two more interaction 
domains present in SPT6: first, an RNA-binding S1 domain that is essential in protein 
translation as it interacts with the ribosome and mRNA and second, a SH2 domain that 
mediates interaction with the phosphorylated CTD of RNAPII (Dronamraju and Strahl, 
2014). 
 
 
Figure 6: Schematic representation of SPT6 domain structure. Acidic N-terminal region (acidic, aa 
6-245), RNA-binding S1 domain (S1, aa 1217-1286), phospho-tyrosine binding SH2 domain (SH2, aa 
1329-1440), C-terminal domain rich in serine, threonine, proline and glycine (STPG, aa 1552-1831). 
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1.2 Dosage Compensation 
Aneuploidy describes genomic deviation from the normal diploid set of chromosomes. 
Already one century ago aneuploidy was described to be involved in cancer, birth defects and 
impaired cell proliferation (Boveri, 1902). Hence, aneuploidy is not well tolerated in cells, as 
it unbalances the fine-tuned organization of the genome. Spontaneously arising aneuploidies 
have to be discriminated from “natural” monosomies occurring in sex determination. For 
example, sex determination via dimorphic sex chromosomes, like it is found in mammals and 
Drosophila, creates a homogametic genotype (XX) in females, whereas the male genotype is 
heterogametic (XY).  
It is obvious that the chromosomal imbalance resulting from male and female sex 
chromosomes has to be balanced. To adjust levels of products resulting from X-linked gene 
expression heterogametic organisms have evolved different mechanisms grouped under the 
term “dosage compensation” (Lucchesi, 2005). In mammalian females one of the two X 
chromosomes is inactivated, consequently genes are only expressed from the remaining single 
X chromosome. While nematodes reduce transcription from both X chromosomes by half 
(hypotranscription), in Drosophila transcription from the single male X-chromosome is 
increased by twofold (hypertranscription). Although mammals, nematodes and flies use 
different strategies to realize dosage compensation, they all share chromatin-based 
mechanisms to regulate transcription (Figure 7). 
 
 
Figure 7: Mechanisms of dosage compensation in human, nematodes and flies. Dosage 
compensation in humans is characterized by the inactivation of one X chromosome in females. In C. 
elegans the monosomy of the male X chromosome is compensated by twofold reduction of X-linked 
gene expression (hypotranscription) in hermaphrodites. In D. melanogaster gene expression from the 
single male X-chromosome is twofold upregulated (hypertranscription). Numbers indicate the gene dose 
from the distinct chromosomes. 
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1.2.1 The Dosage Compensation Complex of Drosophila melanogaster 
Balancing the monosomy of the X-chromosome in Drosophila males is a crucial process that 
equalizes X-linked gene expression between the two sexes (Gelbart and Kuroda, 2009). Here 
this process results in a twofold increased transcriptional output of X-chromosomal genes and 
is mediated by the ribonucleoprotein dosage compensation complex (MSL-DCC). The MSL-
DCC consists of five proteins MSL1, MSL2, MSL3 (Male-Specific-Lethal 1, 2, 3), MLE 
(Maleless), MOF (Males-absent-On-the-First) and two redundant non-coding roX RNAs 
(roX1 and roX2; Figure 8). In males, the MSL-DCC is specifically targeted to actively 
transcribed genes on the X chromosome where MOF exhibits acetylation of H4K16, a 
modification correlating with increased transcription (Akhtar and Becker, 2000). 
 
 
Figure 8: Schematic representation of the Drosophila Dosage compensation complex. The 
Dosage compensation complex is composed of five male-specific lethal (MSL) proteins and a non-
coding roX RNA. Three enzymatic activities reside in the DCC: MSL2 is an E3 ubiquitin ligase, MLE is 
an ATP-dependent helicase and MOF is a histone acetyltransferase.  
 
MSL1 functions as a scaffold protein for the complex as it exhibits binding sites for all other 
MSL subunits except MLE. Interaction with MSL2 is achieved via the N-terminal part of 
MSL1 while MSL3 and MOF binding sites are located within the C-terminus of MSL1 
(Morales, 2004; Hallacli, 2012). MSL2 is an E3 ligase found to regulate complex homeostasis 
by ubiquitylation of the MSL proteins (Villa, 2012). MSL3 harbors a chromodomain able to 
bind H3K36me3 at active genes (Larschan, 2007). MLE is an ATP-dependent helicase that 
remodels the roX RNA and triggers complex assembly by ATP-dependent recruitment of 
MSL2 (Maenner, 2013). The histone acetyltransferase MOF is essential for acetylation of 
lysine 16 of histone 4 (H4K16ac) a modification that is strongly enriched on the male X-
chromosome found to be implicated in the derepression of transcription (Bone, 1994; 
Hilfiker, 1997; Akhtar and Becker, 2000). The roX RNAs are essential for X-chromosomal 
targeting and are present in two different forms in Drosophila. roX1 and roX2 support the 
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assembly of the MSL-DCC, yet they differ greatly in size and sequence similarity (Franke 
and Baker, 1999). roX1 is expressed early during embryonic development of both sexes, 
whereas roX2 expression is expressed later exclusively in males (Meller, 2003).  
Both the MSL-DCC proteins and roX RNAs are essential for male but not for female viability 
(Belote, 1980). All DCC-subunits, except MSL2 are expressed in females as well. Yet, it is 
still controversial which impact the DCC proteins have in female flies. Assembly of a 
functional DCC on the X chromosome is restricted to male flies as female flies express the 
splicing regulator SXL (sex lethal) an RNA binding protein that negatively regulates 
translation of MSL2 (Bashaw and Baker, 1997). For this purpose msl2 transcripts contain 
multiple SXL-binding sites both in the 5’ and 3’ untranslated regions of msl2 mRNA (Kelley, 
1995). Depletion of SXL is lethal to female flies due to activation of dosage compensation 
and MSL2 expression. Experiments confirmed that ectopically expressed MSL2 in females is 
sufficient to assemble the DCC on both female X chromosomes. On the other hand ectopic 
expression of SXL in males will result in loss of dosage compensation, consequently these 
males die.  
 
1.2.2 Targeting and assembly of the MSL-DCC to the male X chromosome 
Immunostainings of polytene chromosomes highlight that in the absence of MOF, MLE or 
MSL3 targeting of a subcomplex composed of MSL1 and MSL2 is restricted to a subset of 
binding sites, while painting of the entire chromosome is only achieved once the full complex 
is assembled (Straub and Becker, 2007; Figure 9). 
Indeed, the initial targeting of MSL1 and MSL2 to the male X chromosome is achieved via 
recognition of a subset of distinct sites known as high-affinity sites (HAS) or chromatin entry 
sites (CES) by the MSL2 CXC domain. HAS are distributed along the X chromosome in 
intervals of ~50 kb and were postulated to function as nucleation sites that allow access of the 
MSL-DCC to the X chromosome. Already in the past, recognition of HAS was shown to be a 
highly sequence-dependent step as most of the HAS share a 21 bp GA-rich motif (MSL 
recognition element, MRE). Inserted on autosomes this motif was found to attract the MSL-
DCC and mutations of the MRE in turn abolished MSL-DCC recruitment to these sites 
(Alekseyenko, 2008). While the identification of a specific DNA sequence is crucial in 
understanding the targeting mechanisms the identification the MRE alone is not sufficient to 
explain the X specificity for the MSL-DCC on the male X chromosome. On the one hand the 
MRE is less than twofold enriched on the X chromosome, on the other hand there is also a 
large subset of non-used sites matching the MRE consensus motif (Lucchesi and Kuroda, 
2015). Hence, additional features like chromatin context were proposed to be involved in 
MRE recognition (Alekseyenko, 2012). Recent evidence supports this hypothesis, 
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highlighting that the initial recognition of high affinity sites is both dependent on DNA-shape 
of the underlying motif and a highly specialized motif called PionX (Villa, 2016). 
Interestingly, the X chromosome harbors regions unable to recruit the MSL-DCC, yet those 
regions are occupied by the complex if targeting elements are close by (Nusinow, 2005). This 
observation suggests a “two-step” model for MSL-DCC recruitment to the male X 
chromosome: after the initial targeting of an MSL1-MSL2 core complex to HAS this complex 
provides a platform that invite MSL3, MOF, MLE and the roX RNAs for a full complex 
assembly on the male X chromosome. In a second step the fully assembled MSL-DCC 
spreads from high affinity sites in cis to active genes marked by trimethylation of H3K36. It 
was proposed that the recruitment of the complex from HAS to sites of active transcription is 
carried out by MSL3, as it was shown that MSL3 is able to bind H3K36me3 in vitro 
(Larschan, 2007). Unlike other transcriptional regulators the MSL-DCC does not bind to 
promoters. Instead, the DCC associates with the transcribed middle and 3’ regions of active 
genes (Straub, 2013). Finally, MOF catalyzes the site-specific acetylation of H4K16 
(H4K16ac) on active gene bodies to increase transcriptional output from the single male X 
chromosome in a twofold range. 
 
 
Figure 9: The MSL-DCC specifically targets the male X chromosome. Polytene chromosomes from 
Drosophila melanogaster larvae stained with MSL2 antibodies visualize the X-specific targeting of the 
MSL-DCC to the male X chromosome. In a mof mutant background only a subset of binding sites in 
occupied by MSL2. DNA is counterstained with DAPI. 
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1.2.3 Mechanism of Drosophila dosage compensation 
Recent evidence indicates that dosage compensation is regulated posttranscriptionally 
(Graindorge, 2011). In theory, gene expression can be regulated at different steps during 
transcription initiation, release of RNAPII from pausing or elongation, respectively. A study 
from 2012 suggested that dosage compensation is mediated through increased transcription 
initiation (Conrad and Akhtar, 2012). The authors report nearly twofold enrichment in 
RNAPII occupancy at promoters and slight enhancement of RNAPII release into gene bodies. 
Interpretation of this observation suggests that dosage compensation mainly operates in the 
absence of productive elongation however, transition into elongation might be facilitated. 
Another model for the coordinate regulation of X-linked genes in Drosophila males favors 
enhanced transcriptional elongation. Indeed, several lines of evidence suggest that the 
enhanced expression of X-linked genes is mediated during transcriptional elongation 
(Larschan, 2011; Prabhakaran and Kelley, 2012; Ferrari, 2013). The regulation of 
transcription elongation through alterations in chromatin structure, such as trimethylation of 
lysine 36 of histone H3 (H3K36me3), acetylation of H4K16 or presence of other elongation 
factors was found to be a highly regulated process (Saunders, 2006; Sims, 2004). According 
to an in vitro model H4K16 acetylated regions on the male X-chromosome lead to diminished 
inter-nucleosomal interactions that facilitate nucleosome eviction and RNAPII progression in 
vivo (Straub and Becker, 2007). Reduced steric hindrance on X-linked gene bodies resulting 
from H4K16ac was suggested to be involved in the release of RNAPII from pausing into 
elongation (“jump start”). Indeed, this suggestion was further supported by the increase of 
elongating RNAPII marked by phosphorylation at serine-2 (Ser2P) over X-linked gene bodies 
(Regnard, 2011). As H4K14ac levels increase RNAPII density on X-linked gene bodies is 
gained (“gain”). Taken together, this “jump start and gain model” explains the coordinated 
expression of X-linked genes through an acetylated chromatin template that facilitates 
transcription elongation (Ferrari, 2013). 
In the human system MSL2 was shown to be directly involved in the facilitation of 
transcription elongation though its E3 ubiquitin ligase activity. MSL2-mediated ubiquitylation 
of H2B (H2Bub) in turn facilitates the methylation of H3K4 and H3K79 (Wu, 2011). Both 
H2Bub and H3K79 methylation represent histone marks important for transcription 
elongation (Minsky, 2008). 
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1.2.4 Properties and functions of MSL2 
The male specific MSL2 protein features several characteristic domains: RING, CXC and 
Pro-Bas domain (Figure 10). The conserved N-terminal RING domain is essential for dosage 
compensation and enables self-ubiquitylation as well as ubiquitylation of the other MSL 
proteins (Villa, 2012). Moreover, the RING finger mediates the interaction with MSL1 
(Copps, 1998). Both CXC and proline/basic-residue rich domains (Pro-Bas) are implicated in 
the identification of DNA elements on the X chromosome. MSL2 is implicated in the binding 
of HAS, as lack or mutation of the CXC domain results in diminished targeting of MSL2 to 
distinct reporter regions as well as disturbed MSL-DCC localization on the X-territories 
(Fauth, 2010). The structural basis of CXC binding to DNA was resolved and highlighted that 
a single arginine is involved in the readout of a dinucleotide sequence from the minor grove 
(Zheng, 2014). Moreover, the DNA binding capacity of the Pro-Bas and CXC DNA-binding 
surfaces was only recently refined in more detail demonstrating that the non-conserved Pro-
Bas domain is implicated in general DNA binding, whereas the CXC region selectively 
recognizes the X chromosome using the PionX motif (Villa, 2016). 
 
 
Figure 10: Schematic representation of MSL2 domain structure. RING domain (really interesting 
new gene, aa 41-85), cysteine-rich region (CXC, aa 525-561), proline-rich Pro-Bas region (PB, aa 685-
713). 
 
1.2.5 Properties and functions of MOF 
The histone acetyltransferase MOF is one of the best-characterized proteins of the MSL-DCC 
(Figure 11). Two well-characterized and highly conserved domains are present in the MOF 
protein: chromo-barrel domain (CBD) and histone acetyltransferase domain (HAT). Unlike 
other chromodomains that target methylated lysine residues, the MOF chromobarrel domain 
(CBD) lacks a structural feature that abolishes methyl-lysine binding (Nielsen, 2005). Instead 
the MOF CBD is implicated in binding of nucleic acids (RNA and DNA) both in vitro and in 
vivo (Akhtar and Becker, 2000; Nielsen, 2005). Based on the structural homology within its 
HAT domain MOF belongs to the family of MYST HATs, defined by the presence of the 
highly conserved MYST (HAT) domain that comprises the acetyl-CoA binding site 
(Marmorstein and Trievel, 2009). Most MYST domains are characterized by the presence of a 
C2HC zinc finger (Yang, 2004). In Drosophila MOF the C2HC zinc finger is crucial for both 
HAT activity and nucleosome binding in vitro (Akhtar and Becker, 2001). Absent in the 
human ortholog, Drosophila MOF exhibits a large and unstructured N-terminus of roughly 
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350 aa with a highly acidic character (pI ~3.88). For a long time no specific function was 
assigned to the MOF N-terminus, however recently it was described to fulfill sex-specific 
functions essential for male viability (Conrad, 2012). 
 
 
Figure 11: Schematic representation of MOF domain structure. Chromo-like chromobarrel domain 
(CBD, aa 370-476), histone acetyltransferase (HAT, aa 538-824), C2HC zinc finger (Zn, aa 575-592). 
 
As MOF is targeted to ectopic sites exhibited H4K16 acetylation activity leads to 
derepression of transcription. Hence, MOF was proposed to be in involved in the activation of 
X-linked genes (Akhtar and Becker, 2001). However, the function of MOF exceeds sole 
histone acetylation activity. For example MOF exhibits autoacetylation activity on K605, 
which resides in the highly conserved region of the C2HC zinc finger domain (Kadlec, 2011). 
Point mutants of K605 or disruption of the zinc finger leads to lack of MOF enzyme activity, 
suggesting a critical involvement of K605ac for MOF substrate specificity and HAT activity. 
Furthermore, MOF is able to acetylate MSL3 at K116, a modification that affects the 
interaction between MSL3 and RNA and ultimately leads to the fine-tuning of dosage 
compensation (Buscaino, 2003). Alternatively, MOF also participates in a complex consisting 
of NSL1, NSL2, NSL3, MCRS2, MBD-R2, and WDS. This complex was termed the NSL 
(non-specific lethal) complex since disruption of respective genes is lethal in both sexes 
(Mendjan, 2006). The evolutionarily conserved NSL complex acts as a major transcriptional 
regulator for housekeeping genes in Drosophila (Feller et al. 2012). ChIP-Chip experiments 
from adult flies revealed that in females MOF colocalizes with MBD-R2 at the 5’end of most 
actively transcribed genes. Whereas in the context of the MSL-DCC MOF is enriched 
together with MSL1 on the coding regions of actively transcribed X chromosomal genes. 
Induction of dosage compensation in female flies though ectopic reconstitution of the MSL-
DCC results in redistribution of MOF from the autosomes to the X chromosome suggesting 
that MOF distributes between the MSL-DCC and the NSL complex (Prestel, 2010). 
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1.3 Ubiquitylation 
Ubiquitin is a highly conserved, 76-residue regulatory protein that is found ubiquitously in 
eukaryotes. It was first described due to its involvement in protein turnover and degradation 
via the proteasome (Ciechanover, 1980; Hershko, 1980). However, today it is clear that the 
attachment of ubiquitin onto substrate protein not only serves a proteolytic signal, but also 
acts as a key mechanism in the regulation of diverse cellular mechanisms such as DNA repair, 
signal transduction, modulation of chromatin structure and intracellular trafficking.  
 
1.3.1 The mechanism of ubiquitin attachment onto substrate protein 
The posttranslational attachment of ubiquitin onto substrate protein relies on a cascade of 
three sequential enzymatic reactions: ubiquitin-activating enzyme E1, ubiquitin-conjugating 
enzyme E2 and ubiquitin protein ligase E3 (Hershko and Ciechanover, 1992). In the first step 
of the ubiquitylation cascade, ubiquitin is activated by adenylation via E1 on its C-terminal 
glycine residue. An ATP-dependent two-step reaction generates a high-energy E1-thiol-ester-
ubiquitin intermediate. The activated ubiquitin is subsequently transferred to a specific 
cysteine residue in the active site of E2. The family of E3 ubiquitin ligases carries out the 
final transfer of ubiquitin from E2 to the substrate. E3 ligases are crucial for substrate 
recognition and can be divided into two groups distinct in structure and sequence of their 
catalytic modules: HECT (homology to the E6AP carboxyl terminus) and RING (really 
interesting new gene) proteins. HECT domain containing E3 ligases catalyze reactions in 
which the enzyme form intermediate thioesters with ubiquitin at their active site cysteine 
residue before the ubiquitin moiety is finally transferred to the substrate. In contrast, RING 
finger containing E3 ligases act as scaffolds binding both E2 and the substrate to ensure 
proximity for efficient and direct transfer of the activated ubiquitin from E2 to the substrate 
(Özkan, 2005).  
Most organisms exhibit one or two E1 enzymes with promiscuous specificities capable of 
transferring the activated ubiquitin moiety to almost any E2 enzyme. In contrast, the class of 
E2 and E3 enzymes is more diverse reflecting the specificity of substrate selection for 
ubiquitin conjugation. Two E1 enzymes (Pelzer et al., 2007; Groettrup, 2008), 37 E2 enzymes 
(Markson, 2009; Michelle, 2009) and >600 E3 ligases are encoded in the human genome 
(Deshaies and Joazeiro, 2009). The Drosophila genome encodes only one E1 enzyme (Watts, 
2003), 32 E2 enzymes (Michelle, 2009) and roughly 150 E3 enzymes (Du, 2011). 
 
  
1 INTRODUCTION 
23 
1.3.2 Diversity of ubiquitylation 
Ubiquitylation of substrate protein emerges in different ways. The posttranslational 
modification of lysine residues can be carried out on a single lysine (monoUb), multiple 
lysines (multi-monoUb) or a single lysine with a polymeric chain of ubiquitin (polyUb) 
(Figure 12; Strieter and Korasick, 2012). A significant layer of complexity is added to the 
ubiquitin signaling network by the fact that formation of polyUb chains bears the opportunity 
to form diverse branched chains and linkages. As all seven lysine residues (K6, K11, K27, 
K29, K33, K48, K63) and the N-terminal methionine residue of the ubiquitin molecule can 
serve as acceptors of further ubiquitin molecules, various chains with different types of 
linkages and lengths may arise in vivo (Xu, 2009; Dammer, 2011). 
 
 
Figure 12: Types of ubiquitylation. Ubiquitin modifications can be arranged in various ways on the 
substrate protein. Addition of a single ubiquitin molecule results in monoubiquitylation (monoUb). 
Addition of more than one ubiquitin moiety to different sites on the target protein is referred to as multi-
monoubiquitylation (multi-monoUb). Conjugation of ubiquitin chains to a distinct target residue is 
considered a polyubiquitylation (polyUb). If the ubiquitin molecules within a chain are linked always via 
the same residue is will result in linear polyubiquitin chains. In contrast branched polyubiquitin chains 
(branched polyUb) result if the ubiquitin molecules are linked via different lysines on ubiquitin. 
 
1.3.3 Biological consequences of ubiquitylation 
Whereas attachment of ubiquitin is still considered to be a classical proteolytic signal recent 
achievements in the field highlight that ubiquitylation is a complex signal that can lead to a 
variety of biological signals. Monoubiquitylation of a target protein is implicated in diverse 
processes such as modulation of protein-protein interactions, cellular localization 
transcription regulation or modulation of cell differentiation (Husnjak, 2012; Mosesson, 2009; 
Sussman, 2013). In contrast, addition of multiple monoubiquitylation to substrate protein was 
linked to endocytosis and cell signaling (Chen and Sun, 2009; Haglund, 2003). The main role 
for polyubiquitin chains can still be attributed to the labeling of target protein for proteasomal 
degradation via the 26S proteasome (Xu, 2009). For example lysine 11, 29 and 48 
polyubiquitin chains mediate proteasome-dependent degradation of target protein (Johnson, 
1995; de Bie, 2010; Matsumoto, 2010) whereby a tetramer of K48-linked Ub-chains was 
described to be the minimal proteolytic signal (Hershko and Ciechanover, 1998). 
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Polyubiquitin chains are composed of identical subunits, yet ubiquitin chains linked through 
K48 and K63 exhibit conformational differences. These differences in structure are crucial for 
interactions of the modified target with distinct ubiquitin-binding proteins (Dikic, 2009) and 
may explain the different properties and functions. K63-linked chains are not only involved in 
non-proteolytic actions by regulating the target’s function during DNA repair (Chen and Sun, 
2009) but also typically facilitate protein-protein interactions required for signal transduction 
(Skaug, 2009). Moreover, intracellular trafficking to the lysosome/vacuole, activation of 
transcription factors and regulation of histones was described to be dependent on K63 
mediated ubiquitylation (Braun and Madhani, 2012; Praefcke, 2012). The atypical lysine 6-
linked polyubiquitin chains have been linked to autoubiquitylation activity of specific E3 
ligases such as the Polycomb complex protein RING1B (Ben-Saadon, 2006). It is obvious 
that ubiquitin conjugation is a highly complex network that regulates crucial processes of 
distinct nature. Thus, study of ubiquitin modifications is an important yet challenging task  
In Drosophila the MSL2 RING domain is able to exhibit ubiquitylation activity on the MSL-
DCC. While this function is crucial to maintain a balanced stoichiometry of the dosage 
compensation complex, MSL2-dependent ubiquitylation might fulfill roles apart from 
proteasomal targeting. Likewise, human MSL2 (hMSL2) was suggested to ubiquitylates the 
tumor suppressor p53 promoting cytoplasmic p53 localization without affecting the stability 
(Kruse and Gu, 2009). In addition, MSL2 together with MSL1 acts as a histone ubiquitin 
ligase that specifically ubiquitylates H2B at lysine 34, a modification involved in the trans-
regulation of H3K4 and H3K79 methylation (Wu, 2011). Moreover, hMSL2 was implicated 
in the modification and stabilization of 53BP1 a key repair protein that acts in response to 
DNA damage (Lai, 2013).  
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1.4 Objective 
 
While it has been shown that MSL2-mediated ubiquitylation of the MSL-DCC proteins is 
used to maintain a balanced stoichiometry of the complex (Villa, 2012), MOF ubiquitylation 
could play an additional role apart from proteasomal targeting. The attachment of ubiquitin is 
still considered to be a classical proteolytic signal, however achievements in the field reveal 
that ubiquitylation is a complex modification that can lead to a variety of biological signals. 
MSL2-related ubiquitylation of MOF thus might be involved in roles apart from proteasomal 
targeting. This thesis provides a comprehensive analysis of MOF ubiquitylation. To analyze 
the functions of MOF ubiquitylation Lys to Arg (K>R) point mutants were generated and 
characterized both in vivo and in vitro using recombinant protein, stable cell lines and 
transgenic flies, respectively. Recombinant MOF mutant protein was employed in in vitro 
ubiquitylation assays to analyze modification pattern of both MSL2-mediated and MSL2-
independent ubiquitylation. Furthermore, histone acetylation assays were performed to 
estimate enzymatic activity of generated MOF mutants. Stable cell lines were generated to 
analyze MSL-DCC assembly and X-territorial targeting. Transgenic fly lines expressing MOF 
mutants were analyzed for their male viability. Using a mass spectrometry-based approach 
the first comprehensive analysis of MOF ubiquitylation pattern in vitro and in vivo was 
generated. Furthermore the first ubiquitylome from S2 cells has been obtained highlighting 
the complexity and magnitude of ubiquitylation present in Drosophila. 
Previous experiments performed in collaboration with Tiziana Bonaldi (IFOM-IEO Campus, 
Milan) revealed that MSL2 targets potential substrates outside of the MSL-DCC as well. Due 
to its involvement in transcriptional elongation SPT6 was chosen as a candidate protein. 
Monoclonal antibodies directed against SPT6 were generated and characterized in Western 
blot and immunofluorescence. Expression and purification of recombinant SPT6 was 
employed for in vitro ubiquitylation assays in the presence of MSL2. 
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2.1 Materials 
2.1.1 Chemicals 
Acetic acid (VWR); Acrylamide Rotiporese Gel 30 (Roth); Agarose (Bio & Sell); Ampicillin 
(Roth); Anti-FLAG M2 Agarose beads (Sigma); ATP (Sigma); Bovine serum albumin, 
(Sigma); Bromophenol blue (Serva); 2-Chloroacetamide (Sigma); Complete Protease 
Inhibitor Cocktail Tablets (Roche); Coomassie Brilliant Blue (Sigma); DAPI (4’,6-diamidino-
2-phenylindole), (Invitrogen); DMSO (Dimethylsulfoxide), (Sigma); dNTP mix (NEB); DTT 
(Dithiotreithol), (Roth); Effectene Transfection Reagent (Quiagen); ECL Advance Western 
Blotting Detection Kit (VWR); EDTA (Sigma); EDTA (Ethylenediaminetetraacetic acid), 
(Sigma); EGTA (Ethylenglycol-bis(2-aminoethyl)-N,N,N’,N’-tetraacetic acid), (Sigma); 
Ethanol (Sigma), Ethidium bromide (Sigma); Fetal bovine serum (Sigma); GFP-Trap A 
(Chromo Tek GmbH); Glycerol (Merck); β-glycerophosphate (Sigma); Glycogen (Roche); 
GST-Mdm2/HDM2 (R&D Systems); Hepes (N-(2-hydroxyethyl)piperazine-H´-(2-
ethanesulfonic acid), (Roth); His6-Ubiquitin (R&D Systems); Hygromycin B (Life 
Technologies); IPTG (Isopropyl-D-thiogalactopyranoside), (Sigma); Isopropanol (Sigma); 
LB Agar (Serva); Magnesium chloride (VWR); β-mercaptoethanol (Sigma); Methanol 
(Sigma); MG 132 (Enzo Life Sciences); NEM (N-Ethylmaleinimid), (Thermo Fisher 
Scientific); Normal Donkey Serum (Dianova); Normal Goat Serum (Dianova); NP-40 (Igepal 
CA-630), (Sigma); Orange G (Sigma); Paraformaldehyde (Life Technologies); Peptone (BD 
Biosciences); PMSF (Sigma); Potassium chloride (VWR); Protein A Sepharose, Protein G 
Sepharose (Helmholtz Centre Munich, E. Kremmer); Rotiporese® Gel 30 (Roth); Schneider’s 
Drosophila medium (Life Technologies); SDS (Sodium dodecyl Sulfate), (Serva); Sf-900 II 
medium (Invitrogen); SILAC Drosophila medium -Arg/-Lys (Dundee Cell Products); Sodium 
bicarbonate (Sigma); Sodium carbonate (Sigma); Sodium chloride (Serva); Sodium 
deoxycholate (Sigma); Sodium fluoride (Sigma); Sodium orthovanadate (Sigma); 
Penicillin/Streptomycin (Sigma); PMSF (Phenylmethanesulfonyl fluoride), (Sigma); TEMED 
(N,N,N´,N´-Tetramethylethylenediamine), (Roth); Tris (Diagonal); Triton X-100 (Sigma); 
Tween 20 (Sigma); Yeast extract (BD Biosciences). 
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2.1.2 Enzymes, Kits and Markers 
100 bp DNA marker (NEB), 1 kb DNA marker (NEB); Duolink detection reagent 
(#DUO92013, Sigma), Duolink PLA probe anti-mouse minus (#DUO92004, Sigma); Duolink 
PLA probe anti-rabbit plus (#DUO92002, Sigma); Fast SYBR® Green Master Mix (Applied 
Biosciences); GeneElute PCR Clean-up Kit (Sigma); MEGAscript T7 kit (Ambion); Midi- 
and Midiprep Kit (Marchery Nagel); Novex Colloidal Blue Staining Kit (Invitrogen); PCR 
cleanup Kit (Marchery Nagel); peqGOLD Protein Marker IV (Peqlab); Pfu Turbo DNA 
Polymerase (Agilent); Phusion DNA Polymerase (Biolabs); Proteinmarker III (Serva); 
Restriction enzymes (NEB); RNeasy Kit (Qiagen); SuperSkript III First Strand Synthesis 
System (Life Technologies); Taq DNA Polymerase (Biolabs); UbcH5c/E2 enzyme (R&D 
Systems); UBE1/ E1 enzyme (R&D Systems). 
 
2.1.3 Consumables 
1.5 ml and 2 ml reaction tubes (Greiner, Sarstedt), 1.5 ml low binding tubes DNA (Sarstedt); 
1.5 ml low binding tubes Protein (Sarstedt); 15 ml and 50 ml tubes (Sarstedt); Amplify 
solution (Amersham); Cell culture flasks (Sarstedt, Greiner); Cell culture plates (Sarstedt, 
Greiner); Cover slips (Roth); Cryovials (Roth); Filter paper Whatman 3 mm (Whatman); 
Filter tips (Biozym, Gilson, Sorenson); Glass pipettes 5 ml and 10 ml (Hirschmann); 
Glassware (Schott); Laboratory film (Parafilm); LightCycler R 480 Multiwell plate, white 
(Sarstedt); LightCycler R 480 Sealing foil (Sarstedt); Microscope slides SuperFrost (Roth); 
Micro-Spin columns (Bio Rad); Nitrocellulose membrane (Amersham); p81 filter paper 
(Millipore); Pasteur pipettes (Brand), Petridishes (Greiner); Pipette tips (Biozym, Greiner, 
Sarstedt); Protein gel casettes (Invitrogen); Protein gels precast (Serva); Vectashield 
Mounting Medium (Vector Laboratories); X-ray films (Fujifilm). 
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2.1.4 Antibodies 
Table 1: Primary antibodies employed in this study 
Name Type Application Dilution Supplier 
ms aFLAG monoclonal, M2 WB 
IF 
1:5000 
1:200 
Sigma (#F3165) 
rb aFLAG polyclonal IF 1:200 Sigma (#F7425) 
ms aGFP monoclonal IF 1:200 Roche (#11814460001) 
rat aGFP  monoclonal 3H9 WB 1:1000 ChromoTek (#ABIN398304) 
rb aGFP polyclonal IF 1:200 Acris (#TP401) 
ms aLamin T40 WB 1:500 H. Saumweber 
gp aMLE polyclonal GP_16 WB 1:300 C. Regnard (Eurogentec)  
rat aMLE monoclonal 6E11 WB 
IF 
1:1000 
1:400 
E. Kremmer (Helmholtz) 
rat aMOF monoclonal 4D4 IF 1:9 E. Kremmer (Helmholtz) 
rb aMOF polyclonal 
(SA4897) 
WB  
IF 
1:2000 
1:400 
Akthar and Becker, 2000 
rb aMSL1 polyclonal 
 
WB  
IF 
1:1000 
1:400 
E. Schulze 
gp aMSL2 polyclonal WB 1:2000 C. Regnard (Pineda) 
rat aMSL2 monoclonal 1D6 WB 
IF 
1:500 
1:200 
E. Kremmer (Helmholtz) 
rb aMSL2 polyclonal (SABC) WB  
IF 
1:1000 
1:400 
Gilfillan et al., 2006 
rat aMSL3 monoclonal 1C9.5 WB  
IF 
1:50 
1:10 
E. Kremmer (Helmholtz) 
ms aSPT6 monoclonal 26D12 WB 
IF 
1:1000 
1:400 
this thesis 
 
ms aSPT6 
 
monoclonal 25C6 
 
WB 
IF 
1:1000 
1:400 
this thesis 
 
ms aSPT6 monoclonal 28C3 WB 1:50 this thesis 
ms aSPT6 monoclonal 27C1 WB 1:50 this thesis 
ms aUbiquitin monoclonal, FK2 WB 
IF 
1:1000 
1:200 
Merck Millipore (#04-263) 
rb aUbiquitin polyclonal IF 1:200 Merck Millipore (#662099) 
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Table 2: Secondary antibodies employed in this study 
Name Application Dilution  Supplier 
a ms HRP WB 1:20000 VWR (#NA931) 
a rat HRP WB 1:20000 VWR (#NA935) 
a rb HRP WB 1:20000 VWR (#NA934) 
a gp HRP WB 1:50000 Dianova (#706-035-148)   
a ms iRdye 680 WB 1:10000 LI-COR Biosciences (#926-68070) 
a rat iRDye 700 WB 1:10000 Biomol (#612-730-120) 
a rb iRDye 800 WB 1:10000 LI-COR Biosciences (#926-32211) 
a gp iRDye 680 WB 1:10000 LI-COR Biosciences (#925-68077) 
a ms 488 IF 1:400 Jackson Immuno Research (#715-545-151) 
a ms Rhodamine-Red-X IF 1:400 Jackson Immuno Research (#715-296-151) 
a rat Cy3 IF 1:400 Jackson Immuno Research (#712-165-153) 
a rb 647  IF 1:400 Jackson Immuno Research (#711-605-152) 
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2.1.5 Oligonucleotides 
Oligonucleotides were purchased from Biomers (Ulm, Germany), Eurofins MWG Operon 
(Ebersberg, Germany) or Sigma-Aldrich (Taufkirchen, Germany). 
 
Table 3: Oligonucleotides: for molecular cloning 
Name  Sequence 5’ – 3’ Description 
MOF_1_AgeI_rv (SS059) AACCGGTGCCATGGTCAAGGCATCATC Subcloning of MOF 
point and deletion 
mutants from pFastBac1 
to pHspEGFP 
MOF_2_KpnI_fw (SS060) GGGGTACCATGTCTGAAGCGGAGCTGG 
MOF_3_KpnI_fw (SS061) GGGGTACCATGGAGCACGACAACACTTC 
MOF_4_AgeI_rv (SS062) AACCGGTGCGCCGGAATTTCCCGGAG 
MOF_K372R_K381R_fw 
(SS022) 
AATAGATCCTGTCGGGATTTTCGCTTAT
ATCGATCCTTTGCATC Site directed mutagenesis 
of MOF MOF_K372R_K381R_rv 
(SS021) 
GATGCAAAGGATCGATATAAGCGAAAAT
CCCGACAGGATCTATT 
MOF_K532_fw (SS043) CAGGCGGCGCTGGAGAGGGAGCACGAGT
CCATT Site directed mutagenesis 
of MOF MOF_K532_rv (SS044) AATGGACTCGTGCTCCCTCTCCAGCGCC
GCCTG 
MOF_K706R_K715R_fw 
(SS045) 
CTGTCGCGCAGGGAGGGCGTAATCGGTA
GTCCGGAGAGACCGCTCTCG Site directed mutagenesis 
of MOF MOF_K706R_K715R_rv 
(SS046) 
CGAGAGCGGTCTCTCCGGACTACCGATT
ACGCCCTCCCTGCGCGACAG 
MOF_K539R_K541R_K5
45R_fw (SS047) 
CACGAGTCCATTACGAGGATCAGGTACA
TTGATAGGCTGCAGTTTGGCAAC Site directed mutagenesis 
of MOF MOF_K539R_K541R_K5
45R_rv (SS047) 
GTTGCCAAACTGCAGCCTATCAATGTAC
CTGATCCTCGTAATGGACTCGTG 
MOF_K694R_fw (SS048) CGTAAGGGATTTGGAAGGCTACTAATAG
CCTTTAG Site directed mutagenesis 
of MOF MOF_K694R_rv (SS049) CTAAAGGCTATTAGTAGCCTTCCAAATC
CCTTACG 
MOF_K773R_K776R_fw 
(SS050) 
TCCATGAAGATGATCAGGTATTGGAGGG
GCCAGAATGTCATTTGC Site directed mutagenesis 
of MOF MOF_K773R_K776R_rv 
(SS051) 
GCAAATGACATTCTGGCCCCTCCAATAC
CTGATCATCTTCATGGA 
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Table 4: Oligonucleotides for RNA interference 
Name  Sequence 5’ – 3’ Description 
GST_fw 
 
TTAATACGACTCACTATAGGGAGAATGTCCCCTA
TACTAGGTTA Control siRNA GST_rv TTAATACGACTCACTATAGGGAGAACGCATCCAG
GCACATTG 
MOF_fw TTAATACGACTCACTATAGGGAGAATGTCTGAAG
CGGAGCTGGAAC siRNA targeting of MOF 
mRNA MOF_ rv  TTAATACGACTCACTATAGGGAGATTTCTGCTTC
TGCGGCTGC 
MOF3’UTR_fw TTAATACGACTCACTATAGGGAGAAATAAGCTAT
TCTATTGCACC siRNA targeting of 
endogenous MOF mRNA MOF3’UTR_rv TTAATACGACTCACTATAGGGAGATTTAACAAGT
CCAGAGTTTT 
MSL2_fw TTAATACGACTCACTATAGGGAGAATGGCCCAGA
CGGCATAC siRNA targeting of MSL2 
mRNA MSL2_rv TTAATACGACTCACTATAGGGAGACAGCGATGTG
GGCATGTC 
 
Table 5: DNA for in vitro ubiquitylation assay 
Name  Sequence 5’ – 3’ Description 
DBF12-L15  TGCGGCCATCTCTTTCGTTTTGATGTTTCTACGC
CATGTG Generation of dsDNA DBF12-L15  CACATGGCGTAGAAACATCAAAACGAAAGAGATG
G 
 
2.1.6 Plasmids 
All plasmids were sequenced at GATC (Konstanz, Germany) or Eurofins MWG Operon 
(Ebersberg, Germany). Cloning procedures of the individual plasmids listed in Table 6 are 
described in section 2.3 Molecular biology methods. 
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Table 6: Plasmids employed in this study 
Name Source Description Marker 
pBluescript II SK-noLys Gene Cust Synthesized DNA for subcloning 
to pFastBac1 
Amp 
pBluescript II SK-3Lys Gene Cust  
pMT-SPT6-GFP Heun Lab Expression of C-terminally GFP-
tagged proteins in S2 cells 
Amp 
pIB-SPT6-GFP Heun Lab 
pFastBac1-MOF wt-FLAG Becker Lab 
Expression of C-terminally GFP-
tagged proteins in S2 cells 
Amp 
pFastBac1-MOF-2KN-FLAG this study 
pFastBac1-MOF-3KN-FLAG this study 
pFastBac1-MOF-5KN-FLAG this study 
pFastBac1-MOF-7KN-FLAG this study 
pFastBac1-MOF-9KN-FLAG this study 
pFastBac1-MOF-3KC-FLAG this study 
pFastBac1-MOF-9KC-FLAG this study 
pFastBac1-MOF ΔN-FLAG this study 
pFastBac1-MOF Nt-FLAG this study 
pFastBac1-SPT6 fl-FLAG this study 
pFastBac1-SPT6[1]-FLAG this study 
pFastBac1-SPT6[2]-FLAG this study 
pEGFP-hsp-MOF wt-GFP this study 
Expression of C-terminally GFP-
tagged proteins in S2 cells 
Kan 
pEGFP-hsp-MOF-2KN-GFP this study 
pEGFP-hsp-MOF-3KN-GFP this study 
pEGFP-hsp-MOF-5KN-GFP this study 
pEGFP-hsp-MOF-7KN-GFP this study 
pEGFP-hsp-MOF-9KN-GFP this study 
pEGFP-hsp-MOF-3KC-GFP this study 
pEGFP-hsp-MOF-9KC-GFP this study 
pEGFP-hsp-MOF ΔN-GFP this study 
pEGFP-hsp-MOF Nt-GFP this study 
pUAST-AttB-MOF wt-FLAG this study 
Site directed insertion of MOF 
mutants to the fly genome 
Amp 
pUAST-AttB-MOF-2KN-FLAG this study 
pUAST-AttB-MOF-3KN-FLAG this study 
pUAST-AttB-MOF-5KN-FLAG this study 
pUAST-AttB-MOF-7KN-FLAG this study 
pUAST-AttB-MOF-9KN-FLAG this study 
pUAST-AttB-MOF-3KC-FLAG this study 
pUAST-AttB-MOF-9KC-FLAG this study 
pUAST-AttB-MOF ΔN-FLAG this study 
pUAST-AttB-MOF Nt-FLAG this study 
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2.1.7 Insect cell lines and bacterial strains 
2.1.7.1 E.coli strains 
Table 7: Bacterial strains employed in this study 
Strain Genotype Supplier 
E.coli DH5a fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 
Δ(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17 
NEB 
E.coli Stellar F–, endA1, supE44, thi-1, recA1, relA1, gyrA96, phoA, 
Φ80d lacZΔ M15, Δ (lacZYA - argF) U169, Δ (mrr - 
hsdRMS - mcrBC), ΔmcrA, λ– 
Clontech 
E.coli DH10Bac F-mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 
ΔlacX74 recA1 endA1 araD139 Δ(ara, leu)7697 galU 
galK λ-rpsL nupG/pMON14272/pMON7124 
Life Technologies 
 
2.1.7.2 Insect cell lines 
Table 8: Insect cell lines employed in this study 
Strain Organism Origin Source 
Kc D. melanogaster embryonic, dorsal closure stage DGRC 
L2-4 D. melanogaster S2 clone, late embryonic stage Patrick Heun 
Sf21 S. frugiperda pupal ovarian tissue Invitrogen 
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2.1.7.3 Stable Drosophila melanogaster cell lines 
Table 9: Stable cell lines obtained in this study 
Cell line Plasmid Source 
L2-4 MOF wt pHspEGFP 
This thesis 
L2-4 MOF-2KN pHspEGFP 
L2-4 MOF-3KN pHspEGFP 
L2-4 MOF-5KN pHspEGFP 
L2-4 MOF-7KN pHspEGFP 
L2-4 MOF-9KN pHspEGFP 
L2-4 MOF Nt pHspEGFP 
L2-4 MOF ΔN pHspEGFP 
L2-4 MOF-3KC pHspEGFP 
L2-4 MOF-9KC pHspEGFP 
Kc MOF wt pHspEGFP 
This thesis Kc MOF-3KC pHspEGFP 
Kc MOF-9KC pHspEGFP 
L2-4 SPT6-MT pMT/V5-His/lacZ 
This thesis 
L2-4 SPT6-IB pIB 
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2.1.8 Technical devices 
 
Description Supplier 
- 20°C Freezer Liebherr 
- 80°C Freezer Thermo Scientific 
4°C Fridge Liebherr, Siemens 
CASY Cell counter Innovatis 
Cell culture hood B-[MaxPro]2-160, Berner 
Centrifuges Avanti JXN-26 (25-50 rotor) 
Eppendorf 5415R 
Heraeus Megafuge 2.0 
Heraeus Pico17 
Sorvall RC6 Plus (SS-34 rotor) 
Thermo Scientific Multifuge X3R 
Gel documentation system ChemiDoc, Bio-Rad 
Peqlab 
Gel dryer 583 Gel Dryer, Bio-Rad 
Developer machine  Curix, AGFA 
Incubator Drosophila Cell culture HettCube 600R, Hettich 
Incubator Drosophila Fly culture MLR-352H-PE, Panasonic 
Incubation Shaker  Infors, Brunswick 
LightCycler 480 II Roche 
Microscopes Axiovert 200M epifluorescence, Zeiss 
Leica DMIL LED 
Axiostar plus, Zeiss 
Stemi 2000, equipped with KL1500 LCD, Zeiss 
Mini Trans-Blot Electrophoretic Transfer Cell Bio-Rad 
pH 720 pH-meter inoLab 
Pipetboy Neolab 
Pipettes Gilson 
Proteingel chamber Novex Mini-Cell System, Invitrogen 
Scales Sartorius 
Sonifier Branson MD-250 
Spectrophotometer Peqlab Nanodrop ND1000 
Thermomixer Eppendorf 5436 
Vortex VR2 Bachofer 
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2.1.9 Software 
 
Device/ Application Software 
ChemiDoc Bio-Rad Image Lab Software 5.2.1 
Image processing Adobe Illustrator, Adobe Photoshop, Axio Vision 
(Zeiss), FIJI, ImageJ  
LI-COR Odyssey 2.1 (LI-COR) 
Phylogeny analyses Protein BLAST (web browser-based) 
Sequence Alignments MacVector, ApE, Serial Cloner 
Visualization of protein structures PyMOL (DeLano Scientific LLC) 
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2.2 Standard buffers and solutions 
Established standard buffers are listed below. Additional buffers used in individual methods 
are included in their respective method section. 
 
Agarose gel    TAE buffer 
     1% Agarose 
     Ethidium Bromide (6µl) 
Ampicillin stock solution    100 mg/ml Ampicillin (1000x) 
Chloramphenicol stock solution  34 mg/ml Chloramphenicol in Ethanol (1000x) 
Coomassie destaining solution  10% Acetic acic (v/v) 
Coomassie fixing solution   10% Acetic acic (v/v) 
     50% Methanol (v/v) 
Coomassie staining solution  10% Acetic acic (v/v) 
     50% Methanol (v/v) 
     0.1% Coomassie Brilliant Blue R (w/v) 
Ethidium bromide stock solution  10 mg/ml Ethidium bromide (20000x) 
Kanamycin stock solution   10 mg/ml Kanamycin (1000x) 
5x Lämmli loading buffer   250 mM Tris pH 6.8 
50% Glycerol (v/v) 
10% SDS (w/v) 
0.05% Blue Bromophenol (w/v) 
0.5 M DTT 
LB agar plates    LB medium 
     2% Agar (w/v) 
LB medium    1% Peptone (w/v) 
0.5% Yeast extract (w/v) 
1% NaCl (w/v) 
PBS(T) buffer    137 mM NaCl 
2.7 mM KCl 
10 mM Na2HPO4 x 12 H2O 
2 mM KH2PO4 
(0.1% Tween-20 (w/v)) 
RIPA extraction buffer   0,1% SDS (w/v) 
0,5% Deoxycholate (w/v) 
0,5% NP40 (v/v) 
1 mM EDTA 
50 mM Tris pH 7.5 
150 mM NaCl 
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SDS-PAGE running buffer  25 mM Tris base 
192 mM Glycine 
0.1% SDS (w/v) 
Separating gel (7%)   23% Rotiporese® 
375 mM Tris/HCl pH 8.8 
0.1% SDS 
0.07% TEMED 
0.1% Ammonium persulfate  
Stacking gel    17% Rotiporese® 
126 mM Tris/HCl pH 6.8 
0.1% SDS 
0.1% TEMED 
0.1% Ammonium persulfate  
Transfer buffer    25 mM Tris base 
     192 mM Glycine 
     20% Methanol (v/v) 
Urea sample buffer    9 M Urea 
1% SDS (w/v) 
25 mM Tris pH 6.8 
1 mM EDTA 
100 mM DTT 
TAE buffer    40 mM Tris pH 7.6 
     20 mM acetic acid 
     1 mM EDTA 
TE buffer    10 mM Tris pH 8 
     1mM EDTA 
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2.3 Molecular biology methods 
2.3.1 General molecular biology methods 
Standard molecular biology methods like polymerase chain reaction (PCR) for amplification 
of nucleic acids, enzymatic restriction and ligation of DNA fragments were performed 
according to standard protocols (Green and Sambrook, 2012). Preparation and transformation 
of chemically competent E. coli cells were performed according to Inoue (1990). Preparation 
of plasmid DNA was carried out using plasmid purification kits from Macherey-Nagel. DNA 
fragments from agarose gels and PCR reactions used for cloning were isolated and purified 
using the NucleoSpin® Gel and PCR clean-up kit (Macherey-Nagel). 
 
2.3.2 Cloning of FLAG-tagged expression constructs 
For expression of recombinant protein in Sf21 cells different MOF-FLAG wildtype and 
mutant constructs were cloned to pFastBac-1. 
2.3.2.1 Generation of MOF deletion mutants 
MOF ΔN was obtained after restriction of pFastBac1 MOF wt with NcoI/EcoRI, while  
MOF Nt was digested using NcoI/SacI, respectively. Klenow Polymerase was used for the fill 
in of 5’-overhangs and removal of 3’-overhangs. Obtained DNA fragments were purified 
from gel and ligated using Quick T4 DNA Ligase.  
2.3.2.2 Generation of N-terminal MOF mutants 
Generation of MOF K>R point mutants in the N-terminus of MOF was carried out by DNA 
synthesis and site directed mutagenesis. To this end two MOF sequences with either 3 or 7 
lysine to arginine point mutations were synthesized and placed into the pBSRII vector. To 
obtain pFastBac MOF-3KN and pFastBac MOF-7KN synthesized DNA fragments were 
subloned from pBSRII to pFastBac1 using NarI and XbaII restriction sites. Two additional 
K>R (K372R, K381R) point mutations were inserted using specific primers (listed in Table 3) 
for site directed mutagenesis on pFastBac MOF wt, pFastBac MOF-3KN and pFastBac  
MOF-7KN to obtain pFastBac MOF-2KN, pFastBac MOF-5KN and pFastBac MOF-9KN, 
respectively. 
2.3.2.3 Generation of C-terminal MOF mutants 
Generation of MOF K>R point mutants in the C-terminus of MOF was carried out by 
successive site directed mutagenesis. Specific primers (listed in Table 3) were used on 
pFastBac MOF wt to obtain pFastBac MOF-3KC and pFastBac MOF-9KC. 
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2.3.3 Cloning of GFP-tagged expression constructs  
For expression of recombinant protein in Drosophila cell lines MOF inserts were amplified 
from respective pFastBac1 constructs using suitable primer with AgeI and KpnI restriction 
sites (listed in Table 3). Obtained PCR products were purified using Quiagen quick spin 
Clean-up Kit. pHspEGFP vector and amplified inserts were digested using AgeI and KpnI 
restriction enzymes. Vector was further dephosphorylated using SAP (Shrimp alkaline 
phosphatase). Inserts and dephosphorylated vector were purified from gel and ligated using 
T4 DNA Ligase. 
 
2.3.4 Cloning of FLAG-tagged constructs to pUAST-attB 
For site directed insertion of MOF mutants into the fly genome MOF mutant inserts were 
subloned from respective pFastBac constructs to pUAST-attB (Bischof, 2007) using KpnI and 
EcoRI restriction. Inserts and dephosphorylated vector were purified from gel and ligated 
using T4 DNA Ligase.  
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2.4 Cell biological methods 
2.4.1 Maintenance of D. melanogaster and S. frugiperda cell lines 
Tissue culture work was performed under sterile conditions. Media and solutions were 
preheated to room temperature prior to use. Determination of cell number was carried out 
using the CASY cell counter system. To obtain the average cell density of a given cell culture 
flask 50 µl of cell suspension was mixed with 10 ml of CasyTon solution and measured using 
a program adjusted to SL2 or Sf21 cell counting parameters, respectively. 
Drosophila cells were cultivated at 26°C in Schneider’s Drosophila medium containing 
L-glutamine, additionally supplemented with Penicillin, Streptomycin and 10% (v/v) fetal 
calf serum (FCS). Sf21 cells were cultivated at 26°C in Sf-900 II medium supplemented with 
Penicillin, Streptomycin and 10% (v/v) fetal calf serum (FCS). Cell density was maintained 
between 0.5x106 and 5x106 cells/ml to ensure exponential cell growth. 
 
2.4.2 Cryopreservation and thawing of Drosophila cells 
Cells were seeded to a density of 1x106 cells/ml in a 175 cm2 culture flask 3 days prior to 
freezing. Collection of cells was carried out by centrifugation at 500 g for 5 min at room 
temperature. After resuspending the cell pellet in 5 ml freezing medium (FCS + 10% (v/v) 
DMSO) cells were distributed to aliquots of 1 ml each in Cryo vials. To decelerate the 
freezing process vials were placed to an isopropanol freezing chamber and stored at -80°C. 
For long term preservation cells were maintained in liquid nitrogen. 
To thaw cells a frozen stock was thawed rapidly in a water bath set to room temperature. 
Cells were transferred to 20 ml of cultivation medium in a 75 cm2 culture flask. Maintenance 
and further cultivation was performed as described above. 
 
2.4.3 Generation of stable SL2 and Kc cell lines 
Stable Drosophila cell lines were generated by cotransfection of the expression vector and the 
pCoHygro selection vector. One day prior to transfection 1x106 cells were seeded onto two  
10 cm plates in 10 ml growth medium and incubated as described previously. The next day 
2 µg of expression vector and 100 ng of selection vector were transfected to the cells using 
Effectene reagent. In order to transfect two plates per construct double amounts of the 
transfection mix were prepared. Vectors were diluted in EC buffer to a final volume of 
300 µl. Subsequently 16 µl of Enhancer was added and vortexed for 1 sec. After incubation 
for 5 min at room temperature 60 µl Effectene was added, vortexed for 10 sec and again 
incubated for 15 min at room temperature. In the meantime 7 ml of fresh media was carefully 
replaced to the 10 cm culture plates. After the last incubation the transfection mix was 
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supplemented with 3 ml of growth medium and added dropwise to the cells. After 48-72 h the 
two plates were combined in a 75 cm2 culture flask to a final volume of 20 ml, to start the 
selection Hygromycin B was added (300 µg/ml). 5 ml of selection medium (300 µg/ml 
Hygromycin B) was added weekly to the cells for about 3 weeks. Afterwards the selection 
medium was removed and the stable cell line was routinely maintained in 75 cm2 flasks as 
described above. 
 
2.4.4 Whole cell extracts from SL2 and Kc cells 
Analysis of protein content was carried out after preparation of whole cell extract. To this end 
5x106 cells were collected and washed once with cold PBS. The pellet was resuspended in 
200 µl RIPA extraction buffer supplemented with 1 mM Protease Inhibitor, 5 mM N-
Ethylmaleinimid and 15 µM MG132. After 15 min on ice with occasional vortexing the cell 
suspension was cleared by centrifugation at 13000 rpm for 30 min at 4°C. After 
centrifugation 5x Lämmli sample buffer was added to the supernatant and boiled at 85°C for 
10 min. For subsequent protein analysis by Western blotting 0.25x106 cells were loaded per 
lane for SDS-PAGE. 
 
2.4.5 RNA interference in SL2 and Kc cells 
Genomic DNA or a DNA plasmid containing gst cDNA was used as a template in a PCR 
reaction to amplify a PCR product for SXL, MOF or GST RNAi, respectively. Used primers 
contain a binding site for T7 RNA polymerase and are listed in Table 4. Purification of PCR 
products was carried out using the PCR Clean-up Kit according to the manufacturer’s guide.   
The obtained PCR products were used to transcribe dsRNA in vitro using the MEGAscript T7 
kit according to the manufacturer’s guide. Secondary structures were denatured by heating the 
RNA for 10 min at 85°C. To support formation of dsRNA duplexes the RNA was slowly 
cooled down to room temperature. 
For knockdown experiments 2x106 exponentially growing cells were seeded to a 6-well plate 
in 1 ml of Schneider’s Drosophila medium without FCS. 10 µg of dsRNA was added per well 
and placed onto a shaking platform for 10 min at room temperature followed by 50 min of 
incubation at 26°C. Afterwards 2 ml of growth medium was added. To achieve efficient 
knockdown of the target protein cells were incubated for additional 4-7 days at 26°C. Cells 
were collected for immunostaining and Western blot analysis.  
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2.4.6 Immunofluorescence on SL2 cells 
For analysis by immunostaining 0.8x106 cells were seeded onto coverslips and allowed to 
attach for 1 h at room temperature. Cells were washed briefly with PBS and subsequently 
fixed in 2% (v/v) Formaldehyde in PBS for 7.5 min on ice. Permeabilization of the cells in 
PBS supplemented with 0.25% (v/v) Triton X-100 and 1% (v/v) Formaldehyde was carried 
out for additional 7.5 min on ice. Afterwards, cells were washed twice with PBS and blocked 
in PBS containing 3% (w/v) BSA for 1 h at room temperature. All subsequent steps of the 
protocol were performed at room temperature. Cells were incubated for 1 h with appropriate 
primary antibody diluted in blocking solution supplemented with 0.01% (v/v) Triton X-100 
and 1.2% Normal Donkey Serum. Following two washing steps of 5 min each in PBS cells 
were incubated for an additional hour with secondary antibody. Again cells were washed 
twice with PBS for 5 min. DNA was counterstained with DAPI (1 µg/µl in PBS) for 2 min. 
Finally, cells were washed two times with PBS and mounted using 10 µl Vectashield 
mounting medium. The coverslip was sealed to the object slide by nail polish. Detection of 
immunofluorescence was carried out using a Zeiss Axiovert 200 epifluorescence microscope 
equipped with a CDD Camera (AxioCamMR, Zeiss). Images were level adjusted in FIJI and 
edited using Adobe Photoshop CS5 and Adobe Illustrator CS5. 
 
2.4.7 Immunoprecipitation experiments 
2.4.7.1 Immunoprecipitation of transgenic MOF-GFP from stable cell lines 
Whole cell extract from 110x106 cells was prepared as previously described in section 2.4.4 
Whole cell extracts from SL2 and Kc cells using 1000 µl RIPA lysis buffer. 30 µl of 
equilibrated GFP-binder slurry was added to the obtained protein extract and incubated for 3 
h on a rotating wheel at 4°C. Following washing steps were carried out by inverting the 
sample tube 20 times using PBS + 0.1% Triton-X, PBS + 0.1% Triton-X 300 mM NaCl, PBS 
+ 0.1% Triton-X and finally PBS. 0.25% of extract before immunoprecipitation (input) and 
50% of beads were separated by 7% SDS-PAGE as described above. Detection of protein was 
carried out using Western blot analysis. 
2.4.7.2 Immunoprecipitation of transgenic MOF-GFP for mass spectrometry 
Expansion of 1.5x109 cells was carried out using 175 cm2 cell culture flasks. After collection 
cells were washed once with cold PBS and snap frozen in liquid nitrogen. The cell pellet was 
resuspended in 5 ml cold RIPA extraction buffer supplemented with 1 mM Protease Inhibitor, 
5 mM N-Ethylmaleinimid and 15 µM MG132. After 10 min incubation on ice cells were 
lysed on ice using sonification at an amplitude of 15% (3 x 10 s pulses, 20 s pause, Branson 
Digital Sonifier 250D). Lysate was incubated another 15 min on ice with occasional 
2 MATERIAL & METHODS 
46 
vortexing. Finally the cell suspension was cleared by centrifugation at 13000 rpm for 30 min 
at 4°C. 100 µl of equilibrated GFP-binder slurry was added to the obtained protein extract and 
incubated for 3 h on a rotating wheel at 4°C.  
Washing steps were carried out by inverting the sample tube 20 times using PBS + 0.1% 
Triton-X, followed by 3 rounds of washing with PBS enriched for 8 M Urea and 1% SDS. 
Finally beads were washed once more with each PBS + 0.1% Triton-X and PBS. 25% of the 
sample was boiled with 5x Lämmli-DTT and subjected to Western blot analysis together with 
0.02% of extract before immunoprecipitation (input).  
For mass spectrometry analysis 75% of the sample was boiled in 5x Lämmli buffer 
supplemented with 1 mM DTT. After incubation with 5.5 mM 2-Chloroactetamide for 45 min 
at room temperature in the dark the sample was separated by 7% SDS-PAGE. Coomassie 
staining was carried out overnight at room temperature with gentle shaking using Novex 
Colloidal Blue Staining Kit. After destaining the gel with high purity water cut gel slices were 
subjected to mass spectrometry analysis performed by Petra Beli at the Institute of Molecular 
Biology in Mainz.  
 
2.4.8 Precipitation of proteins for ubiquitylome analysis 
Confluent L2-4 or Kc cells were harvested from 4-5 175 cm2 cell culture flasks and washed 
twice in ice-cold PBS. Cell pellet was lysed using a modified lysis buffer (50 mM Tris-HCl, 
pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.1% Na-deoxycholate) supplemented with 
protease inhibitors, phosphatase inhibitors and cysteine peptidase inhibitor N-Ethylmaleimide 
prior to use (1:1000 Roche complete protease inhibitor cocktail, 5 mM β-glycerophosphate, 5 
mM NaF, 1 mM Na-orthovanadate, 10 mM N-Ethylmaleimide). Cells were incubated for 10 
min on ice and centrifuged at 16,000×g for 15 minutes at 4°C. Protein concentration of the 
supernatant was determined using Bradford. 200-250 mg of protein were employed for 
ubiquitylome analysis by mass spectrometry. 4 volumes of ice-cold acetone were added to the 
supernatant and proteins were precipitated overnight at -20°C. Samples were shipped on dry 
ice and further processed by Petra Beli at the Institute of Molecular Biology in Mainz. 
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2.5 Drosophila melanogaster studies 
2.5.1 Generation of transgenic fly lines  
Injection of manipulated pUAST-attB-MOF mutant plasmids was carried out by Genetic 
Services Inc. (Sudbury, USA) and BestGene Inc. (Chino Hills, USA). Fly Stocks were 
maintained at 18°C on standard medium. 
 
2.5.2 Fly crosses for male viability assays 
Complementation of the male-lethal mof 2 was carried out at 25°C. Transgene expression was 
induced by crossing female flies of the genotype mof 2/Fm7a; P{armadillo-GAL4} to male 
y/w; {w+ MOF-FLAG-UAS}. Relative male survival was scored as ratio of male mof2/y; 
P{armadillo-GAL4}/{w+ MOF-FLAG-UAS} to female mof2/+; P{armadillo-GAL4}/{w+ 
MOF-FLAG-UAS}. Fly strains generated in this study are listed in Table 9. 
 
2.5.3 Immunostaining of polytene chromosomes 
For optimal conditions larvae were raised at 18°C until they reached the 3rd instar stage. 
Salivary glands were dissected in PBS. Homogenous fixation of the glands was carried out 
for 30 sec with gentle moving in solution A (3.7% PFA, 1% Triton-X in PBS). Tissue was 
subsequently transferred to solution B (3.7% PFA, 50% acetic acid in PBS) and incubated for 
2.30 min on a cover slip. A poly-L-lysine coated slide was used to take up the coverslip. To 
disrupt cells and nuclei the slide was tapped with a pencil, moved back and forth and finally 
heavily pressed on a blotting paper with the thumb. After snap freezing the slide in liquid 
nitrogen the cover slip was removed using a razor blade and slides were transferred to PBS. 
Prepared chromosome squashes may be stored in 100% methanol at -20°C at this point.  
For immunostaining the slide was incubated in blocking solution (3% BSA, 0.2% NP40, 
0.2% Tween20, 10% non fat dry milk in PBS) with gentle shaking for 1 h. Primary antibodies 
diluted in blocking solution were added onto the slide, covered with a coverslip and incubated 
in a humid chamber for 1 h at room temperature or overnight at 4°C. Slides were rinsed twice 
for 5 min in PBS at room temperature. Two washing steps were carried out for each 15 min at 
room temperature by thoroughly shaking the slides, washing 1 (300 mM NaCl, 0.2% NP40, 
0.2% Tween20 in PBS), washing 2 (400 mM NaCl, 0.2% NP40, 0.2% Tween20 in PBS). 
Again, slides were rinsed in PBS for 5 min. Secondary antibodies were diluted in blocking 
solution and incubated for 1 h in the dark at room temperature. Again, washing steps were 
carried out as described previously (5 min rinse in PBS, followed by washing 1 and washing 
2 for each 15 min at room temperature with heavy shaking). DNA was counterstained with 
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DAPI for 10 min at room temperature followed by another wash in PBS for 5 min. Finally, 
chromosomes were mounted using 40 µl VectaShield. 
Detection of immunofluorescence was carried out using a Zeiss Axiovert 200 epifluorescence 
microscope equipped with a CDD Camera (AxioCamMR, Zeiss). Images were level adjusted 
in FIJI and edited using Adobe Photoshop CS5 and Adobe Illustrator CS5. 
 
2.5.4 Preparation of protein extracts from salivary glands 
Salivary glands of 3rd instar larvae were dissected in PBS and subsequently transferred to 2.5x 
Lämmli-DTT. After macerating the glands carefully the sample was boiled for 10 min at 
85°C with heavy shaking. For subsequent Western blot analysis 3-5 pairs of salivary glands 
were loaded to SDS-PAGE. 
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2.6 Biochemical methods 
2.6.1 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Reducing SDS-PAGE was carried out for separation of proteins using the Novex Mini-Cell 
system (Invitrogen). Samples complemented with Lämmli sample buffer were loaded to 
suitable polyacrylamide gels. SDS-PAGE was carried out according to standard protocols at 
30-60 mA at room temperature for varying time. Protein size was determined using various 
molecular weight standards purchased from Peqlab or Serva. Afterwards SDS-polyacrylamide 
gels were used for either Coomassie staining or Western blotting. 
 
2.6.2 Coomassie staining of protein gels 
Following SDS-PAGE polyacrylamide gels were fixed in fixing solution for 30 min at room 
temperature. Proteins were stained with Coomassie Brilliant Blue G-250 (0.0025% (w/v)) in 
fixing solution for 1 h and finally destained with 10% (v/v) Acetic acid until protein bands 
became visible.  
 
2.6.3 Western Blot 
Proteins separated by reducing SDS-PAGE were transferred to a nitrocellulose membrane 
using a wet transfer system (Mini-PROTEAN). Wet transfer was performed in transfer buffer 
at a constant current of 300 mA (6.25 mA/cm2) for 80 min at 4°C. To minimize background 
by unspecific protein-protein interactions the membranes were blocked in 3% (w/v) BSA in 
PBS for 30 min at room temperature. Membranes were probed with an appropriate dilution of 
primary antibody overnight at 4°C. Removal of unspecific bound proteins was achieved by 
extensive washing (3x 10 min) with PBS-T. Subsequently, the membranes were incubated 
with horseradish- or infrared dye-coupled secondary antibody for 1h at room temperature. 
After repeated washing antigen-antibody complexes were detected using the enzymatic 
activity of the horseradish peroxidase conjugated to the secondary antibody. 
Chemiluminescence was detected using ECL Immobilon Western reagent in combination 
with X-ray films or the Chemidoc detection system. When using infrared dye-coupled 
secondary antibodies the membranes were dried prior to detection of proteins using the 
LI-COR Odyssey Infrared Imaging System. 
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2.6.4 In vitro ubiquitylation assay 
Assays were carried out in 20 µl of reaction buffer (25 mM HEPES pH 7.6, 70 mM KCl, 
5 mM ATP, 0.6 mM DTT) in the presence of 55 ng E1 (Boston Biochem, E-305), 263 ng E2 
(Boston Biochem, E2-627), 500 ng MSL2, and 1 mg of substrate protein at 30°C. Reaction 
was stopped after 1 h by addition of 5x Lämmli loading buffer. Sample was subjected to 
SDS-PAGE and immunoblotting. In vitro ubiquitylation assays in the presence of nucleic 
acids contained 1 µM of annealed DBF12-L15 dsDNA. dsDNA was obtained by annealing 
equimolar concentrations of complimentary oligonucleotides in annealing buffer (10 mM 
Tris-HCl pH 7.5, 50 mM NaCl, 0.1 mM EDTA). To support formation of dsDNA duplexes 
the DNA was slowly cooled from 95°C down to room temperature. 
 
2.6.5 Histone acetylation assay 
HAT assays were performed using 1.5 µg of recombinant histone H4 or 0.44 µg of 
nucleosomal histones, respectively. In addition 3µM [3H]acetyl-CoA, 200 ng of recombinant 
MOF protein were combined in a final volume of 20 µl containing 50 mM KCl, 50 mM Tris 
(pH 7.8) and 0.1 mM EDTA. Samples were incubated for 1 h at 26°C. Half of each reaction 
was spotted onto p81 filters, washed three times with 50 mM Na-Carbonate (pH 9.3) and the 
filters were counted in a scintillation counter. Incorporation of [3H]acetate was determined as 
a general measure of HAT activity. The remainder of the reaction was used to visualize 
[3H]acetylated proteins by 4-20% SDS-PAGE. The gel was treated with amplify solution and 
incubated on a shaker for 30 min. For autoradiography the gel was dried and X-ray films were 
exposed for 5-7 days at -80°C. 
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2.7 Expression and purification of MSL-DCC proteins in Sf21 cells 
2.7.1 Generation of recombinant Baculovirus 
Recombinant Baculoviruses were obtained using suitable pFastBac1 vectors and the Bac-to-
Bac expression system according to the manufacturer’s instructions (Invitrogen). In this study 
Baculoviruses for protein expression of MOF K>R point mutants as well as MOF deletion 
mutants and SPT6 protein were obtained. Baculoviruses for MSL2 expression were generated 
in the lab before. 
 
2.7.2 Infection of Sf21 cells with Baculovirus 
Expression of C-terminally FLAG-tagged proteins was performed using recombinant 
Baculoviruses. Sf21 cells (100 ml, 1x106 cells/ml) were infected with the optimal amount for 
each virus, previously determined in test expressions. Cells were harvested after 3 days of 
protein expression. The cell pellet was washed with ice-cold PBS, snap frozen in liquid 
nitrogen and stored at -80°C. 
 
2.7.3 Preparation of Sf21 cell extracts 
For preparation of whole cell extracts obtained Sf21 cell pellet was rapidly thawn in a water 
bath at room temperature and subsequently placed on ice. 10 ml of lysis buffer was added and 
cells were carefully resuspended.  
Lysis buffer: 50 mM HEPES pH 7.6 
  0.3 M KCl 
  5% (v/v) Glycerol 
  0.05% (v/v) NP-40 
  1 mM MgCl2 
  0.5 mM EDTA 
Lysis buffer was further supplemented with protease inhibitors prior to use. 
For MSL2 purification 0.05 mM ZnCl2 was added to the lysis buffer.  
After incubation for 10 min on ice cells were lysed on ice by sonication (4 x 10 sec, 15% 
amplitude, 20 sec pause) using Branson Digital Sonifier. To remove cell debris the lysate was 
centrifuged 30 min at 16000 rpm and 4°C, followed by a second centrifugation step for 
another 15 min. Obtained supernatant containing the soluble protein fraction was subjected to 
protein purification using anti-FLAG M2 Agarose beads. 
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2.7.4 Purification of FLAG-tagged MSL-DCC proteins from Sf21 cell extracts 
200 µl of anti-FLAG M2 Agarose slurry was equilibrated with lysis buffer, added to the 
obtained soluble protein fraction and incubated for 2.5 h at 4°C on a rotating wheel. 
Following incubation washing steps were carried out using at least 10 ml of chilled buffer. 
First, beads were briefly washed with lysis buffer, followed by a second washing step for 
5 min at 4°C on a rotating wheel. A high salt (1 M KCl) washing step of 10 min at 4°C on a 
rotating wheel reduced non-specific protein interactions with the beads. Finally the beads 
were washed another time with lysis buffer for 5 min followed by two quick washes in 
appropriate elution buffer. Elution buffer is composed as the lysis buffer but contained 
50 mM KCl for MOF and SPT6 purification and 100 mM KCl/ 0.05 mM ZnCl2 for MSL2 
purification, respectively. 
Elution of the FLAG-tagged proteins from the beads was achieved by addition of 0.5 mg/ml 
FLAG-peptide in a total volume of 400 µl. After incubation at 4°C on a rotating wheel for 3 h 
the eluted protein was separated from the FLAG-beads using Micro-Spin columns. Protein 
yield after elution was usually high for MOF and full length SPT6 while MSL2 and SPT6[1] 
needed further concentration, which was carried out using Amicon Ultra-4 centrifugal filter 
devices. Obtained proteins were snap frozen as small aliquots and stored at -80°C. 
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3.1 In vitro characterization of MOF ubiquitylation 
3.1.1 MOF is ubiquitylated by MSL2 in vitro 
It was previously reported that FLAG-tagged Drosophila MSL2 from recombinant protein 
expression exhibits robust ubiquitylation activity on MOF and the other DCC subunits in 
vitro (Villa, 2012). To identify MOF ubiquitylation sites recombinant MOF was subjected to 
in vitro ubiquitylation assays. Ubiquitylation assays contained MOF substrate, MSL2 (E3 
ligase), recombinant E1 and E2 enzymes, His-ubiquitin and ATP. Modified MOF was 
digested with trypsin and subjected to mass spectrometry (Petra Beli, IMB Mainz). 
Ubiquitylated peptides were identified by the characteristic mass shift resulting from the 
attachment of two glycine residues that originate from the C-terminus of ubiquitin on the 
branched peptide (Figure 13). Analysis of three biological replicates revealed that 
ubiquitylated lysine residues are distributed all over MOF (Figure 14A). 
 
 
Figure 13: Detection of ubiquitylation sites using mass spectrometry. Ubiquitylated proteins are 
digested with trypsin. Tryptic peptides are fractionated, desalted and subjected to LC-MS/MS analysis. 
Ubiquitylated peptides characterized by a diglycine modification on the lysine residue are identified 
using MaxQuant software. 
 
To further evaluate MOF ubiquitylation FLAG-tagged MOF lysine to arginine (K>R) point 
mutants either in the N-terminus (KN) or the C-terminus (KC) were employed (Figure 14B). 
Ubiquitylation is a highly promiscuous modification and targets other lysines as well, if the 
favored site is not accessible anymore. Consequently, not only the lysines identified by mass 
spectrometry were modified but also the few surrounding lysine residues in the N-terminus. 
As there are only nine lysine residues present within the first 400 aa of MOF, the introduction 
of N-terminal mutants was particularly easy. In total five N-terminal MOF K>R point mutants 
were obtained (Figure 14B; 2KN, 3KN, 5KN, 7KN and 9KN). On the contrary, the C-
terminal part of MOF is highly structured and displays multiple lysine residues. Using the 
structural prediction of human MOF HAT domain (Kadlec, 2011) homologous lysines were 
identified in the Drosophila MOF and assessed according to their accessibility. Finally, two 
C-terminal MOF point mutants with either 3 or 9 K>R point mutations were generated 
(Figure 14B; 3KC and 9KC). In addition, two deletion mutants were generated, either 
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exhibiting the MOF N-terminus alone (Nt) or lacking the N-terminus (ΔN). Recombinant 
MOF mutant protein was purified from a C-terminal FLAG tag using the Sf21 expression 
system in combination with Baculovirus infection. Coomassie-stained protein preparations 
are depicted in Figure 14C. Recombinant proteins were subjected to in vitro ubiquitylation 
and histone acetylation assays. 
 
Figure 14: Investigation of recombinant MOF protein in vitro. (A) Schematic representation of MOF 
wt protein. MOF contains an unstructured N-terminal domain and two globular domains: chromobarrel 
domain and histone acetyltransferase domain (light and dark gray boxes). A C2HC zinc finger is located 
within the HAT domain (dashed box). Black bars indicate lysine residues identified by mass 
spectrometry after in vitro ubiquitylation reaction of MOF wt in presence of MSL2. Bold and light bars 
represent residues found ubiquitylated in 3 out of 3 and 1 out of 3 biological replicates, respectively. (B) 
Schematic representation of domain structure in MOF wt, N-terminal (KN) MOF K>R point mutants, C-
terminal (KC) MOF K>R point mutants and MOF deletion mutants. Recombinant MOF mutant protein 
was purified from the C-terminal FLAG-tag (black boxes). Black bars indicate mutated lysine residues. 
Asterisks indicate modified lysine residues identified by mass spectrometry after in vitro ubiquitylation 
reaction of MOF wt in presence of MSL2. (C) Coomassie-stained SDS-PAA gels of recombinant MOF 
proteins obtained after FLAG-purification. Positions of molecular mass marker proteins are indicated to 
the left (kDa). Full-length MOF protein migrates at 130 kDa, the deletion mutants MOF ΔN and Nt 
migrate at 55 and 80 kDa, respectively. 
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3.1.2 In vitro ubiquitylation of MOF mutants by MSL2 
Previous results obtained from mass spectrometry indicated that in vitro MSL2 modifies 
lysine residues all over MOF. To further investigate MOF ubiquitylation pattern recombinant 
MOF wt, K>R point mutants, ΔN and Nt mutants obtained after FLAG-purification were 
subjected to in vitro ubiquitylation assays in the presence of MSL2 as described above. Using 
a dual-color infrared imaging system (LI-COR) bands from anti-ubiquitin antibody were 
aligned with corresponding bands from MOF-specific antibody to identify ubiquitylated 
species of MOF in Western blot (Figure 15). Western blot analysis revealed that MSL2 
ubiquitylates MOF wt, 2KN, 3KN and 5KN to similar extents, while ubiquitylation of 7KN 
and 9KN was dramatically reduced (Figure 15A). anti-MOF background signal observed 
without MSL2 present in the reaction is displayed in lane 7 (Figure 15A). A hallmark of E3 
ligases is the ability to exhibit autoubiquitylation activity. This characteristic feature can be 
observed as MSL2 is placed into an ubiquitylation reaction without any further substrate 
protein (Ctrl, lane 8). Autoubiquitylation of MSL2 was also detected in reactions 5 and 6 as 
reduced ubiquitylation activity on 7KN and 9KN results in changed substrate specificity of 
MSL2. Interestingly, loss of potential C-terminal ubiquitylation sites did not change the 
overall amount of ubiquitylated MOF species, as MOF wt, 3KC and 9KC were ubiquitylated 
by MSL2 to similar extents (Figure 15B). Upon deletion of the unstructured N-terminus 
ubiquitylated forms of MOF were not detectable anymore (Figure 15C). In contrast, MOF Nt 
acted as a substrate for MSL2 in vitro ubiquitylation (Figure 15D). Taken together these 
observations demonstrate that in vitro MOF is modified by MSL2 predominantly in the N-
terminus. 
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Figure 15: In vitro ubiquitylation of recombinant MOF mutants. (A) In vitro ubiquitylation assay 
using recombinant MOF wt and N-terminal K>R MOF point mutants. Ubiquitylation assays contained 
recombinant E1 and E2 enzymes, His-ubiquitin and ATP. MSL2 and different MOF substrates were 
added to the reactions as indicated. Ubiquitylated proteins were detected using anti-ubiquitin (aUb, top) 
and anti-MOF (aMOF, bottom) antibodies. Positions of molecular mass marker proteins are indicated to 
the left (kDa). Asterisks indicate bands that correspond to ubiquitylated forms of MOF protein. MSL2 
ubiquitylates MOF wt, 2KN, 3KN and 5KN, ubiquitylation of 7KN and 9KN is impaired. In the absence of 
MSL2 MOF wt is not ubiquitylated. Without substrate present in the reaction autoubiquitylation of MSL2 
is observed (Ctrl). (B) In vitro ubiquitylation assay using recombinant MOF wt and C-terminal K>R MOF 
point mutants. MSL2 ubiquitylates MOF wt, 3KC and 9KC to same extents. (C) In vitro ubiquitylation 
assay using recombinant MOF wt and MOF ΔN deletion mutant was performed as described previously. 
MOF ΔN is not ubiquitylated by MSL2 in vitro. (D) In vitro ubiquitylation assay using recombinant MOF 
Nt demonstrates that MOF Nt is a substrate for MSL2 ubiquitylation in vitro. 
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3.1.3 MOF is ubiquitylated by a DCC-unrelated E3 ligase in vitro 
In the presence of MSL2 N-terminal MOF point mutants exhibiting either seven or nine K>R 
replacements demonstrated a decent reduction of ubiquitylation in vitro (Figure 15A). Despite 
numerous lysine residues present in the C-terminal part of the protein, both 7KN and 9KN as 
well as MOF ΔN failed to get ubiquitylated by MSL2, highlighting that the N-terminus is the 
predominant site for MOF modification by MSL2 in vitro. To evaluate whether N-terminal 
MOF ubiquitylation by MSL2 can be attributed to a distinct MSL-DCC-related pattern, 
ubiquitylation assays with a MSL-DCC-unrelated E3 ligase were performed. To this end 
Mdm2 was employed, an E3 ligase known to promiscuously modify a diverse set of proteins. 
Moreover, 9KN mutant was employed in Mdm2 in vitro ubiquitylation assays to evaluate 
whether an E3 ligase with different properties than MSL2 might be able to modify this mutant 
in vitro (Figure 16). In comparison to MSL2 Mdm2 exhibited a more pronounced 
ubiquitylation activity both on itself as well as on putative substrates (Figure 16A, lanes 1 and 
2). Ubiquitylation on MOF wt was considerably higher when placed by Mdm2 (lane 5). 
While MSL2 failed to ubiquitylate 9KN (lane 7), the MSL-DCC-unrelated Mdm2 readily 
modified 9KN in vitro (lane 8). 
In order to investigate whether Mdm2 targets different lysines than MSL2 and may exhibit an 
MSL-DCC unrelated ubiquitylation pattern, the ubiquitylation sites were mapped. To this end 
half of the reaction was loaded for Western blot analysis and the other half was subjected to 
mass spectrometry. In addition, MOF 9KN was employed to determine whether loss of N-
terminal ubiquitylation sites led to increased C-terminal ubiquitylation by Mdm2 to 
compensate for the lack of N-terminal modification. Again, Mdm2 exhibited robust 
ubiquitylation activity on MOF wt and was also able to modify 9KN as shown by Western 
blot analysis (Figure 16B). Modified lysine residues on MOF wt after Mdm2 ubiquitylation 
were found all over the protein with a similar pattern like found on MOF ubiquitylated by 
MSL2 in vitro before: 8 out of 10 Mdm2 sites were found after MSL2 ubiquitylation as well 
(Figure 15C). Two C-terminal sites were found exclusively after Mdm2 but not after MSL2 
ubiquitylation. One N-terminal site was unique to MSL2 ubiquitylation, however this lysine 
was found ubiquitylated in only one biological replicate (K145, Figure 14B). As proposed, 
MOF-9KN acquired additional ubiquitylation sites: compared to MOF wt four additional 
lysines were ubiquitylated by Mdm2 in the C-terminus. 
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Figure 16: MOF is ubiquitylated by an MSL-DCC unrelated E3 ligase in vitro. (A) MOF wt and 9KN 
were subjected to in vitro ubiquitylation reaction using either MSL2 or Mdm2 as described previously. 
Ubiquitylated proteins were detected using anti-ubiquitin (aUb, top) and anti-MOF (aMOF, bottom) 
antibodies. Positions of molecular mass marker proteins are indicated to the left (kDa). Asterisks 
indicate bands that correspond to ubiquitylated forms of MOF protein. Two different exposures (low and 
high) are shown. (B) In vitro ubiquitylation assay of MOF wt and 9KN by MSL2 and Mdm2, respectively. 
Ubiquitylation assays were carried out as described previously and subjected to mass spectrometry. 
Ubiquitylated proteins were detected using anti-ubiquitin (aUb, top) and anti-MOF (aMOF, bottom) 
antibodies. Positions of molecular mass marker proteins are indicated to the left (kDa). Two different 
exposures are provided (low and high exposure). Asterisks indicate bands that correspond to 
ubiquitylated forms of MOF protein. (C) Schematic representation of modified lysine residues in MOF wt 
and 9KN after ubiquitylation with indicated E3 ligases in vitro. MOFwt/MSL2 ubiquitylation pattern as 
already depicted in Figure 14A is provided for comparison. Black bars indicate ubiquitylated lysine 
residues. Asterisks indicate modified lysine residues identified by mass spectrometry after in vitro 
ubiquitylation reaction of MOF wt in presence of MSL2. 
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3.1.4 Allosteric modulation of MSL2 ubiquitylation activity 
MSL2 directly interacts with HAS DNA in vitro and in vivo (Straub, 2008; Fauth, 2010; 
Zheng, 2014; Villa, 2016), it was explored whether the E3 ligase activity of MSL2 would be 
modulated by DNA binding. To this end in vitro ubiquitylation assays on MOF wt in the 
presence of saturating amounts of DNA (Fauth, 2010; 3XDBF-12-L15) were performed 
(Figure 17). MSL2 exhibits robust ubiquitylation activity on MOF wt while addition of DNA 
to the reaction dramatically reduced MOF ubiquitylation pattern. This experiment suggests 
that the enzymatic activity of MSL2 can be allosterically modulated by DNA binding, a 
reaction that might contribute to regulated MSL-DCC assembly in vivo. 
 
 
Figure 17: Allosteric modulation of MSL2 ubiquitylation activity. In vitro ubiquitylation assay in 
presence of DNA. Assays were performed as described previously. Saturating amount of DNA (1 µM; 
3XDBF-12-L15) was added to the reaction as indicated. Ubiquitylated proteins were detected using anti-
ubiquitin (aUb, top) and anti-MOF (aMOF, bottom) antibodies. Positions of molecular mass marker 
proteins are indicated to the left (kDa). Asterisks indicate bands that correspond to ubiquitylated forms 
of MOF protein. The experiment was repeated at least 3 times with same outcome. 
 
3.1.5 Enzymatic activity of MOF derivatives 
To determine enzymatic and functional consequences of K>R or deletion mutants, 
respectively, the most prominent MOF mutants were employed in histone acetylation assays 
on both free H4 histones and nucleosomes. To this end, incorporation of [3H]acetyl was 
analyzed using in vitro histone acetylation assays as a readout of enzymatic activity. In a first 
screen recombinant protein was subjected to HAT assays on purified histone H4. MOF wt 
and H4 were added as negative controls exhibiting no detectable HAT activity (Figure 18, 
lanes 1 and 6). MOF Nt alone had barely detectable acetylation activity as the HAT domain is 
missing from this deletion mutant (Figure 18, lane 5). Interestingly, MOF wt, 9KN and ΔN 
were able to acetylate H4 (Figure 18, lanes 2-4) even in the absence of MSL1 and MSL3 
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which is in contrast to previous findings that indicated that activity of MOF is stimulated only 
upon addition of MSL1 and MSL3 (Morales, 2004). Furthermore, hyperacetylation activity of 
MOF ΔN on histone H4 as described in literature (Conrad, 2012) was not observed in this 
experimental setup.  
 
 
Figure 18: HAT activity of selected MOF derivatives on H4 histones in vitro. HAT assays were 
performed using 1.5 µg of recombinant histone H4, 3µM [3H]acetyl-CoA, 200 ng of each recombinant 
MOF wt and MOF mutant protein in a 20 µl reaction containing 50 mM KCl, 50 mM Tris (pH 7.8) and 
0.1 mM EDTA. Samples were incubated for 1 h at 26°C. Half of each reaction was used for 
autoradiography to visualize [3H]acetylated proteins (left panel) and the other half was used to 
determine incorporation of [3H]acetate as a general measure of HAT activity (right panel). Positions of 
molecular mass marker proteins are indicated to the left (kDa). Arrowheads indicate migration of H4, ΔN 
and respective MOF full-length derivatives. The experiment was performed in 2 biological replicates with 
the same outcome. 
 
Next, HAT assays on nucleosomal substrates in the presence of MSL3 and MSL1 were 
performed as interaction of MOF with an MSL1-MSL3 subcomplex was described to increase 
specificity and efficiency of the acetyltransferase reaction (Morales, 2004). To this end MOF 
wt, the most dramatic N-terminal mutants (9KN and ΔN) as well as both C-terminal MOF 
mutants (3KC and 9KC) were employed. 
In accordance with literature, addition of MOF alone did not have any detectable acetylation 
activity (Figure 19, lane 8). Upon addition of MSL1-MSL3 to the acetylation reaction MOF 
exhibits autoacetylation as well as acetylation of MSL3 and MSL1 (Figure 19, lane 7), 
whereby most of the acetyl groups are incorporated into MSL1. Once nucleosomes are added 
to the reaction, acetyl groups are also incorporated into histone H4 (lane 1). As MOF-9KN 
mutant is employed incorporation of acetyl groups was comparable to MOF wt (Figure 19, 
lane 4). In contrast, C-terminal MOF K>R mutants displayed subtle changes in enzyme 
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activity compared to MOF wt. While 9KC, exhibited slightly increased acetylation activity on 
histone H4, the mutant with fewer point mutations (3KC) surprisingly acetylated both MSL1 
and histone H4 to a higher extent (Figure 19, lane 2 and 3). 
In conclusion, N-terminal mutation of lysine residues does not affect MOF acetylation 
activity in vitro neither on free histone H4 nor on histone H4 in a nucleosomal context in the 
presence of an MSL1-MSL3 subcomplex. However, C-terminal MOF mutants that carry 
point mutations within the HAT domain, exhibited changes in substrate specificity. 
 
 
Figure 19: HAT activity of MOF wt, 3KC, 9KC and 9KN on nucleosomes in vitro. (A) HAT assays 
were performed using 0.44 µg of nucleosomal substrates, 3µM [3H]acetyl-CoA, 1.5 pmol of each 
recombinant MSL1-MSL3 subcomplex, MOF wt and MOF K>R mutants as indicated (3KC, 9KC, 9KN) in 
a 20 µl reaction containing 50 mM KCl, 50 mM Tris (pH 7.8) and 0.1 mM EDTA. Samples were 
incubated for 1 h at 26°C. Half of each reaction was used for autoradiography to visualize [3H]acetylated 
proteins (left panel) and the other half was used to determine incorporation of [3H]acetate as a general 
measure of HAT activity (right panel). Positions of molecular mass marker proteins are indicated to the 
left (kDa). Arrowheads indicate migration of H4, MSL3, respective MOF full-length derivatives and 
MSL1. The experiment was performed in 2 biological replicates with same outcome. 
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3.2 In vivo characterization of MOF ubiquitylation 
3.2.1 MOF is ubiquitylated in vivo 
Ubiquitylation assays on recombinant MOF protein clearly demonstrated that MOF can be 
modified by the two employed E3 ligases, MSL2 and Mdm2, in vitro. In order to examine to 
which extent MOF is ubiquitylated in vivo both endogenous as well as transgenic MOF 
mutants were analyzed using different approaches. 
Proximity ligation assays (PLA) are more sensitive and specific than traditional 
immunosassays and allow the detection of protein-protein interactions as well as protein 
modifications. Fixed cells that stably express MSL2-GFP were stained with anti-MOF and 
anti-ubiquitin antibodies. Oligonucleotides (PLA-probes) attached to secondary antibodies 
hybridize and form a circular DNA molecule if the probes are in close proximity (≤ 40 nm). 
The DNA circle is amplified using rolling circle amplification and incorporation of 
fluorescently labeled oligonucleotides is used to visualize the PLA signal. Ubiquitylated MOF 
protein was detected in MSL2-GFP cell lines as PLA signals that represent interaction foci of 
MOF and ubiquitin (Figure 20A). Suitable controls were included to assess the specificity of 
anti-MOF/anti-ubiquitin PLA staining (Figure 20B). The first row depicts a representative 
PLA experiment using anti-MOF and anti-ubiquitin primary antibodies. Multiple interaction 
foci (PLA) distributed all over the nuclei and the cytoplasm indicate the colocalization of 
MOF and ubiquitin. PLA signal was gone when only one antibody was utilized or when the 
cell was depleted for MOF by RNA interference demonstrating the specificity of this method. 
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Figure 20: Detection of MOF ubiquitylation in vivo. (A) Cell lines stably expressing MSL2-GFP were 
subjected to PLA assays to detect MOF ubiquitylation in vivo. The proximity of MOF and ubiquitin is 
visualized by interaction foci (red dots, PLA). GFP stains transgenic MSL2-GFP, DNA was 
counterstained with DAPI. Magnification highlights the localization of MOF/ubiquitin interaction foci 
(PLA) throughout the cell. MSL2 enriches at the X-territory (GFP). Scale bars represent 1µm. (B) 
Assessment of PLA specificity using anti-MOF (aMOF) and anti-ubiquitin (aUb) antibodies. To test 
specificity of anti-MOF/anti-ubiquitin PLA staining MSL2-GFP cell lines were employed. The PLA signal 
is gone upon staining with anti-ubiquitin only (second row). Loss of PLA signal is also observed using 
anti-MOF and anti-ubiquitin antibodies on cells depleted for MOF protein after 7 days of MOF RNAi 
(third row). GFP stains transgenic MSL2-GFP, DNA was counterstained with DAPI. Scale bars 
represent 1µm. 
 
Since proximity ligation cannot be used to identify at which residues MOF is modified, an 
ubiquitylome from S2 cells was generated using mass spectrometry. To this end proteins from 
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whole cell extracts were precipitated and ubiquitylated proteins were enriched using di-
glycine antibodies. Mass spectrometry of the immunoprecipitated protein fraction revealed an 
ubiquitylome that comprises more than 1000 proteins (preliminary data, one data set only). 
Within the sample, MOF was found to be modified on 7 lysine residues distributed within the 
C-terminal region of MOF chromobarrel and HAT domain (Figure 21). Interestingly, 4 of the 
lysine residues were also found to be ubiquitylated by MSL2 in vitro before (Figure 14A; 
K372, K532, K715, K798). 
 
 
Figure 21: Ubiquitylome from S2 cells reveals MOF ubiquitylation sites in vivo. Ubiquitylated 
protein fraction was isolated from S2 cells using di-glycine antibody and subjected to mass 
spectrometry. Black bars indicate modified lysine residues on the MOF protein. CBD (chromobarrel 
domain), HAT (histone acetyltransferase domain). 
 
To determine whether identified lysine residues are modified in a dosage compensation-
related manner, yet another mass spectrometry approach was followed. MOF-GFP was stably 
transfected into both male (S2) and female (Kc) cell lines. Using the GFP-trap resin MOF was 
recovered from whole cell extracts and subjected to Coomassie staining (Figure 22B). High 
molecular weight bands above the unmodified MOF-GFP protein fraction were considered to 
be ubiquitylated forms of MOF. In fact, Western blot analysis using anti-ubiquitin and anti-
MOF antibodies together with the dual color infrared system (see above) revealed that the 
high molecular weight bands correspond to ubiquitylated forms of MOF (Figure 22A). Slow 
migrating protein bands were isolated from Coomassie gels, trypsin digested and subjected to 
mass spectrometry. In the course of 4 (S2 cells) and 2 (Kc cells) biological replicates, 
respectively, N-terminal MOF ubiquitylation was never detected (Figure 22C). Instead, 
C-terminal MOF ubiquitylation seems to dominate in vivo. When comparing MOF 
ubiquitylation patterns derived either from male or female cells no lysine residues were found 
that are modified only in males but not in females. In fact, there is even one additional site 
ubiquitylated on MOF derived from female cells. 
In summary, a large pool of ubiquitylated MOF was detected both in the nucleus and 
cytoplasm of Drosophila cells. Interestingly, modified lysine residues detected on MOF-GFP 
after immunoprecipitation were predominantly found in the C-terminus, but not in the N-
terminus in vivo highlighting a discrepancy between MOF ubiquitylation in vitro and in vivo. 
Similarities in ubiquitylation pattern between MOF derived from either male or female cells 
suggest that MSL2-independent ubiquitylation dominates in vivo. 
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Figure 22: In vivo ubiquitylation pattern on MOF derived from male and female cells. (A) MOF-
GFP was recovered from male (S2) and female (Kc) cells stably transfected with MOF-GFP using the 
GFP-trap resin. Ubiquitylated species of MOF were detected in Western blot using anti-MOF (aMOF, 
left) and anti-ubiquitin (aUb, right) antibodies. Asterisks indicate bands that correspond to ubiquitylated 
forms of MOF protein. Western blots were exposed at either low (top) or high (bottom) exposure. 
Positions of molecular mass marker proteins are indicated to the left (kDa). (B) Sample preparation for 
mass spectrometry of MOF in vivo ubiquitylation sites. MOF-GFP was recovered from male (L2-4) and 
female (Kc) cells stably transfected with MOF-GFP using the GFP-trap resin. 75% of the sample was 
loaded to 7% SDS-PAGE for coomassie staining and modified protein fraction was cut from the gel as 
indicated by black boxes. Proteins were trypsin digested followed by subsequent analysis of 
ubiquitylated lysine residues by mass spectrometry. (C) Schematic representation of MOF in vivo 
ubiquitylation sites identified by mass spectrometry after isolation of MOF-GFP from stably transfected 
cell lines (S2, male; Kc, female). MOF ubiquitylation sites detected in S2 and Kc cells are displayed as 
black bars, numbers indicate modified lysine residues. The experiment in S2 cells was carried out in 4 
biological replicates, 2 biological replicates were performed in Kc cells. CBD (hromobarrel domain), HAT 
(histone acetyltransferase domain). 
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3.2.2 Analysis of MSL2-dependent MOF ubiquitylation in vivo 
Previous analyses had revealed that MOF is readily ubiquitylated both in vitro and in vivo. 
However, in vivo it has to be assumed that MOF is not only modified by MSL2 but also by 
several other E3 ligases present in the cell. A common approach to determine whether 
ubiquitylation of a given substrate is dependent on a distinct E3 ligase has been provided by 
target-specific double stranded RNAs that abolish the synthesis of the respective E3 ligase. 
Despite efficient dsRNA have already been successfully employed to specifically deplete 
MSL2 in S2 cells, a major limitation of the approach arises from the fact that any interference 
with MSL-DCC composition results in codepletion of associated complex members. 
However, in the context of both endogenous MOF and MOF-GFP, the transgenic protein 
might be less affected by MSL2 depletion. To study MOF-GFP ubiquitylation in dependency 
of MSL2 an RNAi mediated approach was employed using a dsRNA, spanning 400 bp of the 
msl2 cDNA to deplete for MSL2 protein in stably expressing MOF-GFP cells. As a control 
for non-specific effects of RNA interference, cells were treated with as dsRNA that 
specifically targets the mRNA of glutathione-S-transferase (GST).  
While in the context of a stably transfected MOF-GFP cell line it was observed that 
endogenous MOF levels were co-depleted as expected, amounts of transgenic MOF-GFP 
were mostly unaffected as shown by in Western blot analysis (Figure 23A). Using these 
observations PLA experiments were carried out on stable MOF-GFP cells to assay the 
amount of ubiquitylation on MOF in dependency of MSL2. To this end cells depleted for 
either MSL2 or GST were fixed according to standard procedures and stained with suitable 
primary antibodies directed against GFP and ubiquitin. To estimate the amount of 
ubiquitylation on transgenic MOF-GFP PLA was applied as described previously. 
Remarkably, the number of interaction foci seemed to be independent of MSL2 (Figure 23B) 
suggesting that MOF is susceptible to modifying E3 ligases also outside the MSL-DCC. Still, 
it has to be taken into account that the proportion of MOF-GFP after MSL2 RNAi might also 
reflect the fraction of MOF-GFP outside the MSL-DCC. 
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Figure 23: RNAi of MSL2 in transgenic MOF-GFP cell lines. (A) Transgenic S2 MOF-GFP cell lines 
were treated with dsRNA targeting the mRNA of GST or MSL2, respectively. Western blot analysis was 
performed after 7 days of RNAi. 0.25x106 cells were loaded per lane and probed with anti-Lamin 
(aLamin), anti-MOF (aMOF) and anti-MSL2 (aMSL2) antibodies. Positions of molecular mass marker 
proteins are indicated to the left (kDa). (B) Cell lines stably expressing MOF-GFP were subjected to PLA 
assays to detect MSL2-dependent MOF ubiquitylation in vivo. The proximity of MOF and ubiquitin is 
visualized by interaction foci (PLA-signal). GFP stains transgenic MOF wt-GFP, DNA was 
counterstained with DAPI. Scale bars represent 1µm. 
 
3.2.3 Analysis of proteasome-related MOF ubiquitylation in vivo 
To highlight MSL2-independent ubiquitylation sites on MOF, stable MOF-GFP cell lines 
were treated with the proteasome inhibitor MG132 (Figure 24). Treatment of small numbers 
of cells consistently illustrated the accumulation of ubiquitin signal and MOF-GFP upon 
proteasome inhibition (Figure 24A). In order to obtain satisfactory protein amounts for 
ubiquitin remnant profiling large amounts of cells were raised and treated accordingly. 
Despite several efforts and adjustments ubiquitylated species of MOF-GFP never 
accumulated to comparable amounts as seen before in the small-scale setup (Figure 24B, 
input). In an attempt to analyze ubiquitylation sites after proteasome inhibition, MOF-GFP 
was purified using the GFP-trap, trypsin-digested and subjected to LC-MS/MS (Figure 24B, 
GFP-IP). Analysis of ubiquitin remnants revealed only one ubiquitylated lysine residue 
(K715) on MOF-GFP after MG132 treatment (Figure 24C). The reasons for this poor 
accumulation of ubiquitylated MOF after proteasome inhibition are unclear, as one might 
have expected to detect more ubiquitylation sites as found before on MOF-GFP in steady 
state (Figure 24B). Since amount and quality of detected ubiquitylated peptides also depends 
very much on the performance of the mass spectrometer, biological and technical replication 
is highly recommended. 
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Figure 24: Proteasome inhibition in stable S2 MOF-GFP cells. Stable MOF-GFP cells were 
incubated with 10 µM MG132 for 6 h prior to harvesting. (A) Protein extracts referring to 0.25x106 of 
each untreated and treated cells were loaded for SDS-PAGE and subjected to Western blot analysis. 
Membranes were probed with anti-Lamin (aLamin), anti-MOF (aMOF) and anti-ubiquitin (aUb) 
antibodies. Positions of molecular mass marker proteins are indicated to the left (kDa). Red asterisk 
indicates MOF-GFP, black asterisk indicates endogenous MOF. (B) MOF-GFP was recovered from cells 
stably transfected with MOF-GFP using the GFP-trap resin. 0.25% of input and 25% of IP were loaded 
to SDS-PAGE and subjected to Western blot analysis. Membranes were probed with anti-Lamin 
(aLamin), anti-MOF (aMOF) and anti-ubiquitin (aUb) antibodies. Positions of molecular mass marker 
proteins are indicated to the left (kDa). (C) Schematic representation of MOF-GFP. MOF ubiquitylation 
site identified by mass spectrometry is displayed as black bar, number indicates modified lysine residue. 
One biological replicate is depicted. 
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3.2.4 Characterization of MOF mutants in vivo using immunofluorescence 
Previous experiments revealed a discrepancy of the ubiquitylation pattern obtained on MOF 
in vitro and in vivo. To investigate whether the modifications placed on MOF play a role in 
dosage compensation MOF mutant constructs were employed in S2 cells. Transgenic cell 
lines were established using stable transfection of pHsp70-EGFP MOF derivative constructs. 
MOF-GFP mutant cell lines were subjected to immunofluorescence staining to ascertain their 
X-territory targeting and association with the MSL-DCC (Figure 25). Immunostaining of 
stable cell lines expressing N-terminal MOF-GFP K>R point mutants revealed proper 
targeting to the X-territory and co-localization with associated MSL-DCC proteins. 
MOF ΔN-GFP was slightly reduced on the X-territory, whereas MOF Nt no longer targets the 
X-territory (Figure 25A). MSL-DCC localization to the X-territory does not seem too be 
affected by the expression of N-terminal MOF mutant transgenes. 
C-terminal MOF mutant cell lines were employed using stable transfection of pHsp70-EGFP 
constructs as already mentioned above. However, in this case the cell lines were established 
using a different transfection reagent (Effectene, Quiagen). Accordingly, faithful MOF-GFP 
expression and X-territory targeting were confirmed once more (Figure 25B). 
Immunofluorescence staining of C-terminal MOF K>R mutants revealed that 3KC faithfully 
targeted the X-territory and co-localized with MSL3, whereas for 9KC this was not the case 
(Figure 25C).  
Since transgenic cell lines still contained the functional endogenous MOF protein 
incorporation of the transgenes might be incomplete and cells are not fully challenged to 
incorporate potential impaired MOF-GFP derivatives into the MSL-DCC. To analyze the 
MOF mutants in the absence of endogenous MOF protein RNA interference was employed to 
favor incorporation of the MOF-GFP transgenes into the MSL-DCC. Using suitable primers a 
dsRNA spanning 300 bp within the 3’ untranslated region of the mof gene was designed. As a 
control for non-specific effects of RNA interference, cells were treated with as dsRNA that 
specifically targets the mRNA of glutathione-S-transferase (GST). A subset of K>R mutants 
was selected for RNAi experiments. Due to previous observations from in vitro ubiquitylation 
assays N-terminal 2KN, 7KN and 9KN were of particular interest. While 2KN represents the 
loss of the lysines within the chromobarrel domain, 7KN might phenocopy MOF ΔN. 9KN is 
a combination of the latter two mutants exhibiting loss of all lysines within the first 400 aa of 
MOF. To analyze the impact of loss of C-terminal lysines, both 3KC and 9KC were 
employed. 
3 RESULTS 
71 
 
 
3 RESULTS 
72 
 
Figure 25: Nuclear localization of MOF mutants. (A) Nuclear localization of N-terminal MOF point 
mutants and MOF deletion mutants. Stable cell lines expressing either MOF-GFP or the indicated MOF-
GFP mutants were stained with antibodies against MSL3, MSL1 and GFP as indicated. DNA was 
counterstained with DAPI. Scale bars represent 1 µm. (B) Confirmation of MOF-GFP localization upon 
changed employment of transfection reagent. Cell lines stably expressing MOF-GFP were stained with 
antibodies against MSL3 and GFP as indicated. DNA was counterstained with DAPI. Scale bars 
represent 1 µm. (C) Nuclear localization of C-terminal MOF point mutants. Stable cell lines expressing 
either MOF 3KC-GFP or MOF 9KC-GFP were stained with antibodies against MSL3 and GFP as 
indicated. DNA was counterstained with DAPI. Scale bars represent 1 µm. 
 
After 7 d of RNAi endogenous MOF levels were substantially reduced in the N- and C-
terminal K>R point mutants as shown by immunoblotting of whole cell extracts (Figure 26A 
and B). Stable cell lines depleted for the endogenous MOF protein were subjected to 
immunofluorescence experiments. It had previously been demonstrated that MOF transgenes 
enrich significantly better to the X-territory upon depletion of endogenous MOF protein. 
MOF wt, 2KN, 7KN, 9KN and 3KC target the X-territory as assessed by co-localization with 
MSL3 (Figure 26C). While loss of three potential C-terminal ubiquitylation sites (3KC) is 
still well tolerated, loss of 9 lysine residues (9KC) within the MOF HAT domain resulted in 
loss of GFP signal from the X-territory.  
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Figure 26: Depletion of endogenous MOF protein in transgenic cell lines using RNA interference. 
(A, B) Transgenic S2 cell lines (MOF wt, 2KN, 7KN, 9KN, 3KC and 9KC) were treated with dsRNA 
targeting the 3’ mRNA of the endogenous MOF protein. Western blot analysis was performed after 7 
days of endogenous MOF RNAi. 0.25x106 cells of control (S2) and knockdown samples were loaded 
per lane and probed with anti-Lamin (aLamin) and anti-MOF (aMOF) antibodies. Positions of molecular 
mass marker proteins are indicated to the left (kDa). (C) Nuclear localization of K>R MOF point mutants 
upon knockdown of endogenous MOF protein. Stable cell lines expressing either MOF-GFP wt or the 
indicated MOF-GFP point mutants were stained with antibodies against GFP and MSL3 as indicated. 
DNA was counterstained with DAPI. Scale bars represent 1 µm. 
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To assess differences of X-territory enrichment of both MOF-GFP mutant transgenes and 
MSL3 a quantitative approach was applied. Since the effect upon expression of C-terminal 
MOF mutants was very obvious quantification was restrained to the N-terminal (KN) 
mutants. Using CellProfiler three biological replicates were quantified upon RNAi of 
endogenous MOF protein in S2, wt, 7KN and 9KN, two biological replicates were processed 
for 2KN (Figure 27).  
 
 
Figure 27: Analysis of X-chromosomal territories in S2 cells stably expressing MOF-GFP K>R 
point mutants after RNAi of endogenous MOF protein. (A) Quantification of median MOF-GFP 
signal using GFP antibody. For each cell line the median GFP-signal within the nuclei (segmented on 
the DAPI staining) is plotted. S2 cell line served as non-transfected GFP-negative control. The black bar 
indicates median signal for each cell line, the box plot presents standard deviation. Scaling of the y-axis 
is logarithmic. (B) Quantification of the X-chromosomal territories in transgenic cell lines using GFP 
antibody. For each staining log enrichment ratios were calculated as territorial signals computationally 
segmented on the MSL3 staining and the mean intensity of the nuclei (segmented on the DAPI 
staining). The black bar indicates average GFP enrichment for each cell line. Scaling of the y-axis is 
logarithmic. (C) Quantification of median MSL3 signal in transgenic cell lines using MSL3 antibody. For 
each cell line the median MSL3-signal within the nuclei (segmented on the DAPI staining) is plotted. 
Scaling of the y-axis is logarithmic. (D) Quantification of the X-chromosomal territories in transgenic cell 
lines using MSL3 antibody. For each staining log enrichment ratios were calculated as territorial signals 
computationally segmented on the MSL3 staining and the mean intensity of the nuclei (segmented on 
the DAPI staining). The black bar indicates average MSL3 enrichment for each cell line. Scaling of the 
y-axis is logarithmic. 
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Quantification of median MOF-GFP signals within the nuclei (segmented on the DAPI 
staining) revealed major differences in the expression levels of the MOF-GFP derivatives, 
which was also visible in Western blot, and immunofluorescence microscopy of 
representative areas of the imaged slides. Compared to MOF wt-GFP median levels of 
2KN-GFP were substantially higher, while in 7KN- and 9KN-GFP cell lines median GFP 
levels were particularly low (Figure 27A). GFP-enrichment on the X-territory seemed to 
follow this tendency as MOF wt-GFP and 2KN-GFP enriched to similar extent on the X 
chromosome, while 7KN- and 9KN-GFP enrichment was reduced (Figure 27B). When 
checked for the median MSL3 signal within the nuclei (segmented on the DAPI staining), 
2KN-GFP exhibited highest MSL3 levels, followed by 7KN-, wt- and 9KN-GFP, lowest 
MSL3 median levels were detected in S2 control cells (Figure 27C). At the same time MSL3 
enrichment on the X-territory was highest for wt-GFP, followed by 7KN-, 9KN- and 
2KN-GFP, while MSL3 enrichment on the X-territory was least efficient in S2 control cells 
(Figure 27D). In summary, all K>R mutants display reduced MSL3 enrichment on the X-
territory when compared to MOF wt, however the biological relevance of these observations 
remain to be discussed. 
Notably, median GFP expression levels substantially varied between the employed MOF 
K>R mutants (Figure 27A). Hence, MSL3 enrichment on the X-territory might be dependent 
on relative amounts of the GFP transgenes present in the cells. To evaluate whether median 
GFP-levels affected GFP and MSL3 enrichment on the X-territory, cutoffs on median MOF-
GFP signal in single biological replicates were employed to constrain the analysis to signals 
that represent moderate expression of MOF-GFP (Figure 28A). Remarkably, the replicates 
were quite different regarding the GFP expression levels of the individual MOF mutant cell 
lines. Still, evaluation of average GFP and MSL3 enrichment after application of the cutoffs 
confirmed the previous observations: all K>R point mutants enrich less on the X territory than 
the wt (Figure 28B) and MSL3 enrichment on the X-territory followed the same tendency as 
previously described in Figure 27D (Figure 28C). In summary, varying GFP-expression 
levels cannot be linked to the overall reduction of MSL3 enrichment on the X-territory in the 
K>R mutants. 
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Figure 28: Analysis of X-chromosomal territories in S2 cells stably expressing MOF-GFP K>R 
point mutants after RNAi of endogenous MOF protein. The box plots present standard deviation. 
Scaling of the y-axes are logarithmic. (A) Employed cutoffs on median MOF-GFP signal in the single 
biological replicates. MOF-GFP signals within the nuclei (segmented on the DAPI staining) were 
constrained to signals that represent moderate expression of MOF-GFP. Plots depicted in Figure 27B-C 
were assessed on cells within the cutoff area between the indicated horizontal bars. The bold black bar 
indicates median MOF-GFP signal for each cell line. (B) Quantification of the X-chromosomal territories 
in transgenic cell lines depleted for endogenous MOF protein using GFP antibody. The black bar 
indicates average GFP enrichment for each cell line. (C) Quantification of the X-chromosomal territories 
in transgenic cell lines depleted for endogenous MOF protein using MSL3 antibody. The black bar 
indicates average MSL3 enrichment for each cell line. 
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3.2.4 Association of MOF mutants with the MSL-DCC 
Extensive mutation of C-terminal lysine residues resulted in loss of both MOF Nt-GFP and 
MOF-9KC-GFP from the X-territory as assessed by immunofluorescence (Figure 25A and 
C). This finding points to a diminished assembly of the MSL-DCC upon expression of 
transgenic MOF mutants in vivo. To confirm this assumption immunoprecipitation 
experiments were performed to study the assembly of the MOF mutants with the MSL-DCC. 
To this end MOF deletion mutants and C-terminal K>R point mutants were employed using 
the GFP-trap (Figure 29). Immunopurified MOF ΔN-GFP is able to interact with the members 
of the MSL-DCC, whereas MOF Nt-GFP no longer exhibits any interactions with the 
complex. Signal observed in immunoprecipitation of MOF Nt-GFP with MLE is also 
observed in the non-GFP S2 control and can be attributed to background signal as a 
consequence of MLE sticking to the GFP-trap. Various studies point to a dimeric complex 
composition of the MSL-DCC. Within the MSL-DCC dimerization of MSL1 and the 
interaction with two MSL2 subunits is believed to initiate the assembly of the complex 
(Hallacli, 2012). Furthermore, it was proposed that MLE dimerizes in vitro (Izzo, 2008). To 
date, it is not fully proven whether MOF exhibits homodimerization as well. 
Immunoprecipitation experiments performed on transgenic MOF-GFP however did not reveal 
interaction of MOF-GFP and endogenous MOF (Figure 29A). Immunoprecipitation 
experiments performed on the C-terminal MOF K>R point mutants confirmed that 
immunopurified 3KC-GFP is able to exhibit substantial interaction with MSL1, MSL2, MSL3 
and MLE (Figure 29B). 9KC-GFP on the contrary does not interact with MSL1, MSL2 and 
MSL3. However, 9KC-GFP surprisingly still interacts with MLE, which was unexpected 
since a direct interaction of MOF and MLE was not reported so far.  
In summary, mutation of N-terminal lysine residues does not affect complex association on 
the X chromosome. On the contrary, both a MOF deletion representing the N-terminus only 
as well as extensive mutation of C-terminal lysine residues result in loss of localization on the 
X-territory as well as loss of complex association. 
3 RESULTS 
78 
 
Figure 29: Association of transgenic MOF-GFP mutants with the MSL-DCC. Cell extracts from 
control cells (S2) and stably transfected cells with MOF-GFP derivatives as indicated were 
immunoprecipitated with the GFP-trap. Western blots of input lysates or immunoprecipitates were 
analyzed with antibodies against MOF, MSL1, MSL2, MSL3, MLE and Lamin as indicated. Positions of 
molecular mass marker proteins are indicated to the left (kDa). The experiments were repeated in 
biological triplicates with the same outcome. (A) Association of transgenic MOF-GFP deletion mutants 
with the MSL-DCC. MOF wt-GFP and MOF ΔN-GFP associate with the MSL-DCC, MOF Nt-GFP fails to 
interact with the complex. (B) Association of transgenic C-terminal MOF-GFP K>R point mutants with 
the MSL-DCC. MOF wt-GFP and MOF 3KC-GFP associate with the MSL-DCC, MOF 9KC-GFP 
interacts with MLE only. 
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3.2.5 Male viability of MOF mutants 
To analyze the functionality and impact of the MOF point mutants in the living organism 
transgenic fly lines were generated using site-directed integration of the MOF constructs. 
Transgenic flies harbor MOF mutant constructs on the third chromosome under the control of 
an upstream activating sequence (UAS), furthermore, they exhibit a C-terminal FLAG-tag 
and a mini white reporter construct (w+). To check for proper activation of transgene 
expression the UAS constructs were first induced using a salivary glands tissue specific 
GAL4 driver line. Flies homozygous for the transgene were crossed to flies comprising a 
GAL4 activator downstream of the Sgs3 promoter. Relative expression levels of the MOF 
transgenes were assessed from each 2-4 salivary glands by Western blot analysis (Figure 30). 
 
 
Figure 30: Induction of MOF transgene expression in salivary glands. Homozygous males carrying 
MOF transgenes were crossed to virgin flies carrying the tissue-specific Sgs3-Gal4 salivary gland driver. 
Salivary glands from isogenic W1118 flies were used as control. 2-3 pairs of salivary glands were 
dissected, boiled in sample buffer and subjected to Western blot analysis. Induced MOF transgenes 
were detected using anti-FLAG (aFLAG) antibody. Positions of molecular mass marker proteins are 
indicated to the left (kDa).  
 
Next, the viability of the MOF mutants was assayed by complementation of the male-lethal 
mof 2 mutant (Figure 31). Similar to immunofluorescence experiments before, only a subset of 
MOF mutants was selected for complementation assays (wt, 2KN, 7KN, 9KN, 3KC, 9KC, 
ΔN and Nt). Transgene expression was induced at 25°C by crossing female flies of the 
genotype mof 2/Fm7a; P{armadillo-GAL4} to male y/w; {w+ MOF-FLAG-UAS}. Relative 
male survival was scored as ratio of male mof 2/y; P{armadillo-GAL4}/{w+ MOF-FLAG-UAS} 
to female mof 2/+; P{armadillo-GAL4}/{w+ MOF-FLAG-UAS}. 2KN, 7KN and 9KN rescued 
male lethality of mof 2 to similar extent as the MOF wt transgene (Figure 31A). ΔN and Nt 
deletion mutants dramatically reduced male survival in accordance with literature (Conrad, 
2012a) and were used as internal negative control.  
mof2 complementation efficiency of the C-terminal MOF mutants was observed to be 
dependent on the amount of larvae per vial (Figure 31B). As 100 1st instar were placed to a 
food vial per cross MOF wt, the N-terminal 9KN and the C-terminal 3KC mutant fully 
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restored male viability. Male viability was mildly affected upon expression of 9KC (72%) 
whereas ΔN restored male viability only up to 17%. In contrast, placement of at least 400 1st 
instar larvae per food vial affected overall complementation efficiency of all MOF transgenes 
(Figure 31C). Still, MOF wt, 9KN and 3KC rescued male viability to similar extents. The 
effect of ΔN complementation was more pronounced in the crowded vial as male viability 
drops to 2% compared to 17% in the non-crowded vials. Male viability was strongly 
challenged upon expression of 9KC in the crowded food vials and complements mof 2 only up 
to 33%. 
 
 
Figure 31: Male viability of MOF mutants. (A) Male viability upon expression of N-terminal MOF point 
mutants. Male survival was assayed upon expression of various MOF transgenes in the mof2 male 
lethal background. Average ratios of male mof2/y; P{armadillo-GAL4}/{w+ MOF-FLAG-UAS} flies 
compared to the number of female mof 2/+; P{armadillo-GAL4}/{w+ MOF-FLAG-UAS} flies (relative male 
survival) are shown. Error bars represent the standard error of the mean. The experiment was 
performed in biological triplicates. (B) Male viability upon expression of C-terminal MOF point mutants in 
non-crowded conditions. Average ratios of male mof2/y; P{armadillo-GAL4}/{w+ MOF-FLAG-UAS} flies 
compared to the number of female mof 2/+; P{armadillo-GAL4}/{w+ MOF-FLAG-UAS} flies (relative male 
survival) are shown. Error bars represent the standard error of the mean. The experiment was 
performed in biological triplicates. (C) Male viability upon expression of C-terminal MOF point mutants in 
crowded conditions (≥ 400 larvae per vial). Median ratios of male mof2/y; P{armadillo-GAL4}/{w+ MOF-
FLAG-UAS} flies compared to the number of female mof 2/+; P{armadillo-GAL4}/{w+ MOF-FLAG-UAS} 
flies (relative male survival) are shown. Error bars represent the standard error of the mean. The 
experiment was performed in 5 biological replicates. 
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3.3 MSL2-dependent ubiquitylation outside of the MSL-DCC 
In order to explore whether the E3 ligase activity of MSL2 targets other substrates outside of 
the DCC an unbiased approach was employed previously in the laboratory in collaboration 
with Tiziana Bonaldi (IFOM-IEO Campus, Milan). A stable cell line (S2 cells) expressing 
His6-tagged ubiquitin under the control of a strong promoter was used to perform stable 
isotope labeling by amino acids in cell culture (SILAC). This stable cell line was treated with 
double-stranded interfering RNA for specific knockdown of MSL2 or control GST RNAi, 
respectively. To enrich for ubiquitylated proteins whole cell extracts were subjected to pull 
down experiments using Ni2+ agarose beads. The SILAC analysis provided a set of putative 
substrates for MSL2 dependent ubiquitylation, yet none of the MSL-DCC proteins were 
detected either in input or in the enriched pull-down sample, which is most likely a 
consequence of their overall low cellular abundance. Due to its proposed role in 
transcriptional regulation at the step of elongation SPT6 was chosen as candidate protein for 
further investigations.  
 
3.3.1 Generation and characterization of SPT6 monoclonal antibodies 
To study and characterize SPT6 in Drosophila melanogaster, monoclonal antibodies derived 
from rat and mouse were generated. Suitable epitopes were chosen from both the N-terminal 
and C-terminal part of the protein in accordance with a BLAST research for SPT6 specific 
peptides. Apparently aa 207-491 and aa 1525-1831 show no particular alignment with other 
Drosophila specific proteins so these parts of the protein were chosen for epitope search 
(Figure 32A). Commercial antibodies for both human and mouse SPT6 recognize epitopes 
within the C-terminus of the protein. 
An epitope scan within the preselected regions of SPT6 yielded three potential epitopes 
suitable for antibody generation (Figure 32B). Peptides were synthesized and coupled via a 
cysteine group to ovalbumin by Peps4LS GmbH (Heidelberg). Dr. E. Kremmer (Service Unit 
Monoclonal Antibodies, Helmholtz Zentrum, Munich) employed obtained peptides for 
production of monoclonal antibodies.  
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Figure 32: Generation of SPT6 monoclonal antibodies. (A) Protein sequence of Drosophila SPT6. 
Regions that do not exhibit alignments with other Drosophila proteins (BLASTp) are highlighted in red 
letters. (B) Schematic representation of SPT6 domain structure. Regions and sequences of selected 
peptides employed for generation of monoclonal antibodies are indicated. 
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About 100 supernatants were tested in a first screen for their reactivity in Western blot 
probing Drosophila melanogaster embryo extracts. Eight supernatants contained antigen-
specific antibodies and were selected for further subcloning (Table 10).  
 
Table 10: monoclonal SPT6 antibodies. 
SPT6 antibody epitope host 
26D12 spt6-1 mouse 
25C6 spt6-1 mouse 
13D4 spt6-1 rat 
28C3 spt6-2 mouse 
27C1 spt6-2 mouse 
8C4 spt6-3 rat 
14B8 spt6-3 rat 
17C8 spt6-3 rat 
 
In addition, reactivity of obtained monoclonal antibodies was assessed in 
immunofluorescence experiments on S2 cells. 26D12 and 25C6 hybridoma recognize a 
mostly nuclear protein while staining with 28C3, 27C1, 13D4, 8C4, 14B4 and 17C8 gave an 
unspecific background signal all over the nucleus and cytoplasm (Figure 33). 
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Figure 33: SPT6 monoclonal antibodies in immunofluorescence. 0.8x106 S2 cells were stained with 
antibodies against SPT6, MSL3 or MSL2 as indicated. DNA was counterstained with DAPI. Scale bars 
represent 1 µm. 
 
Finally, the specificity of subcloned SPT6 monoclonal antibodies was further confirmed by 
Western blot analysis and immunofluorescence upon depletion of endogenous SPT6 using 
RNAi interference (Figure 34). A dsRNA, spanning 400 bp within the spt6 cDNA was used 
to deplete SPT6 protein in S2 cells. As a control for non-specific effects of RNA interference, 
cells were treated with a dsRNA that specifically targets the mRNA of glutathione-S-
transferase (GST). After 4 days of SPT6 RNAi protein levels were significantly depleted, 
whereas 7 days of RNAi treatment was lethal for the cells. Whole cell extracts from S2 cells 
depleted for GST or SPT6, respectively were subjected to Western blot analysis (Figure 34B). 
Supernatants 26D12 and 25C6 recognizing peptide spt6-1 and supernatants 28C3 and 27C1 
recognizing peptide spt6-2, were found to specifically detect SPT6 from S2 whole cell 
extracts. Specificity of 26D12 and 25C6 monoclonal antibodies was also confirmed in 
immunofluorescence experiments on fixed S2 cells (Figure 34C). 
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Figure 34: Specificity of SPT6 monoclonal antibodies. (A) Concentrations of different monoclonal 
SPT6 antibodies needed in Western blot and immunostaining experiments. (B) Western blot analysis 
after 4 days of GST and SPT6 RNAi, respectively. 0.25x106 cells were loaded per lane and probed with 
anti-Lamin and indicated anti-SPT6 monoclonal antibodies. (C) 26D12 and 25C6 monoclonal SPT6 
antibodies are specific in immunofluorescence experiments. S2 cell lines were treated wit dsRNA 
against GST (ctrl) or SPT6, respectively. 0.8x106 cells were stained with antibodies against SPT6 and 
MOF as indicated. DNA was counterstained with DAPI. Scale bars represent 1 µm. 
 
In summary, four specific monoclonal SPT6 antibodies were obtained recognizing the N-
terminal epitopes spt6-1 and spt6-2, respectively. Unfortunately, immunization with the C-
terminal spt6-3 peptide did not yield any specific antibodies. Future applications and analyzes 
of potential SPT6 deletion mutants have to consider the epitope specificity accordingly. 
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3.3.2 Purification of recombinant SPT6 protein 
In order to investigate whether SPT6 is a substrate for MSL2-dependent in vitro 
ubiquitylation spt6 cDNA was cloned into the pFastBac1 vector, comprising either aa 1-979 
(SPT6[1]), aa 980-1831 (SPT6[2]) or the full-length sequence of SPT6. Using respective 
Baculoviruses recombinant protein was expressed in Sf21 cells. After 3 days of expression 
cells were harvested and protein was purified from a C-terminal FLAG-tag as described 
previously. For preparation of whole cell extracts cells were lysed, sonified and soluble 
protein fraction was obtained by centrifugation. SPT6, SPT6[1] and SPT6[2] proteins were 
readily expressed as seen from preparations of the cell pellet after centrifugation (Figure 35; 
P). On SDS-PAA gels the protein sizes of SPT6, SPT6[1] and SPT6[2] refer to 250, 160 and 
120 kDa, respectively. While both SPT6 and SPT6[1] were found in the soluble fraction 
(S/N) after centrifugation, formation of inclusion bodies hampered SPT6[2] isolation. SPT6 
and SPT6[1] proteins were eluted to satisfying amounts using 50 mM KCl elution buffer (E). 
 
 
Figure 35: FLAG-purification of SPT6. Coomassie-stained SDS-PAA gel of pellet (P), obtained 
supernatant after centrifugation (S/N) and eluted protein fraction (E). Positions of molecular mass 
marker proteins are indicated to the left (kDa). Predicted positions of recombinant SPT6 derivatives are 
indicated as black dots. 2 µl of eluted protein fraction were loaded to 7% SDS gels.  
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3.3.3 In vitro ubiquitylation of recombinant SPT6  
To assess whether MSL2 exhibits ubiquitylation activity on SPT6 in vitro recombinant SPT6 
proteins obtained from FLAG-purification were subjected to in vitro ubiquitylation assays as 
described previously (Figure 36). Employing both SPT6[1] and SPT6 full-length protein 
Western blot analysis revealed that SPT6 is ubiquitylated in the presence of MSL2 which was 
visualized by the detection of high molecular protein bands (Figure 36A). Suitable controls 
verified the specificity of MSL2-dependent SPT6 ubiquitylation (Figure 36B). 
 
 
Figure 36: In vitro ubiquitylation of SPT6 by MSL2. In vitro ubiquitylation assay using recombinant 
SPT6[1] and full-length SPT6 was performed as described previously. Positions of molecular mass 
marker proteins are indicated to the left (kDa). (A) MSL2 and different SPT6 substrates were added to 
the reactions as indicated. Ubiquitylated proteins were detected using anti-ubiquitin (aUb (mouse), top), 
anti-SPT6 (aSPT6, guinea pig, middle) and anti-MSL2 (aMSL2 (rabbit), bottom) antibodies. (B) MSL2, 
different SPT6 substrates and ATP were added to the reactions as indicated. Ubiquitylated SPT6 was 
detected using anti-SPT6 (aSPT6, 26D12 mouse monoclonal) antibody. 
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4.1 MOF ubiquitylation  
Almost any protein is modified by ubiquitylation at some point of its life cycle. While 
ubiquitylation is best known for its role in proteasomal turnover other ubiquitylation signals 
will not affect stability of the target protein. Within the past years reports on the functions of 
nonproteolytic substrate ubiquitylation have steadily accumulated (Kulathu and Komander, 
2012; Keusekotten, 2013; Fiil, 2013; Corn and Vucic, 2014). The recent discovery that MSL2 
is involved in homeostatic control of the associated dosage compensation complex proteins 
raised the question whether MSL2-mediated ubiquitylation of substrates is implicated in 
biological functions apart from proteasomal targeting (Villa, 2012). Previous analyses had 
already indicated that in vitro MSL2 preferentially ubiquitylates the N-terminal region of 
MOF (unpublished data, Villa). Interestingly, the large and unstructured N-terminus of MOF 
has been proposed to act as a regulator of dosage compensation, which controls the assembly 
of the MSL-DCC on the male X chromosome and modulates MOFs HAT activity (Conrad, 
2012a). Combining these two findings – the N-terminus as a regulatory unit, preferentially 
ubiquitylated by MSL2 in vitro – the aim of the project was initially to explore whether 
ubiquitylation affects the function of the N-terminus and more systematically to characterize 
the involvement of MOF ubiquitylation in the context of dosage compensation. Combining 
biochemical analyses with genetic and cell approaches this study provides the first 
comprehensive characterization of MOF ubiquitylation. 
 
4.1.1 Discrepancies between MOF ubiquitylation in vitro and in vivo 
MOF ubiquitylation by MSL2 in vitro is substantially different from ubiquitylation observed 
on MOF in vivo. In vitro ubiquitylation assays confirmed that MSL2 preferably ubiquitylates 
MOF within the first 400 aa. To determine whether this modification pattern is specific for 
MSL2-mediated ubiquitylation, the generic human E3 ligase Mdm2 was employed. 
Remarkably, both enzymes catalyzed highly similar ubiquitylation reactions. At the same 
time it has to be taken into account that Mdm2 exhibited higher enzymatic activity on the 
MOF substrate, which was reflected by the observation that Mdm2, in contrast to MSL2, was 
able to ubiquitylate MOF-9KN. It therefore remains unclear whether the nature of the 
difference between MSL2 and Mdm2 is qualitative (specificity) or quantitative (avidity). 
To further study MOF ubiquitylation in general and MSL2-dependent MOF ubiquitylation in 
particular in a physiological setting, proximity ligation assays were employed. This approach 
is more specific and more sensitive than traditional immunoassays to detect protein-protein 
interactions or, as in this case, protein modifications (Weibrecht, 2013; Gomez, 2013). The 
appearance of MOF-ubiquitin interaction foci illustrated the presence of ubiquitylated MOF 
species in vivo. Interestingly, the number of interaction foci was not affected upon depletion 
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of MSL2, indicating that observed MOF ubiquitylation in the cell was placed by a different 
E3 ligase. Whereas PLA allows analyses of cell populations with single-cell resolution, it is 
not possible to identify the respective modified residues on MOF. To this end a mass 
spectrometry-based ubiquitylome approach was employed in S2 cells. 
Technical advance within recent years provided refined methods for specific enrichment of 
ubiquitin remnant peptides as well as their detection using high-resolution mass spectrometry. 
Using the expertise of Dr. Petra Beli (IMB, Mainz) ubiquitylome analyses revealed more than 
1000 ubiquitylated proteins in Drosophila S2 cells (preliminary data, one data set only). 
Within this dataset MOF was found modified on 7 lysine residues that clustered in the 
structured regions of HAT and CB domains. In a further attempt to investigate MSL2-specific 
MOF ubiquitylation male and female cells were stably transfected with tagged MOF, purified 
from cells, trypsin digested and subjected to LC-MS/MS. Since female cells lack MSL2 any 
ubiquitylation found there does not relate to dosage compensation. In a first approach MOF-
FLAG was stably expressed in S2 and Kc cells, purified from protein extracts, trypsin 
digested and finally analyzed by LC-MS/MS. The sample complexity observed was very 
high, which prevented efficient identification of single modified lysine residues on MOF-
FLAG. In an optimized approach high salt washing steps were employed using the GFP-trap 
to enrich MOF-GFP stably expressed in S2 or Kc cells. Reduced sample complexity allowed 
identification of ubiquitylated lysines on MOF-GFP in male or female cells and confirmed the 
data obtained from ubiquitylome analysis: modified lysine residues cluster around HAT and 
CB domain, whereas again N-terminal ubiquitylation could not be detected in vivo. 
Furthermore, the comparison of MOF-GFP ubiquitylation pattern derived from male and 
female cells did not highlight male-specific modifications. Instead, most of the modified 
lysines of MOF-GFP were shared in male and female cells. Moreover, MOF-GFP derived 
from female cells exhibited two additional ubiquitylation sites, yet this data has to be judged 
very carefully due to several technical issues. 
Input samples revealed a stronger transgene expression on MOF-GFP derived from female 
cells when probed by Western blot analysis. To assess transgene expression within the 
population, cells were subjected to immunofluorescence microscopy revealing that transgenic 
MOF-GFP was strongly overexpressed in individual cells, male or female. Usually stable cell 
lines employed in this study comprised low numbers of cells with non-physiologically high 
levels of MOF-GFP. By contrast, in the samples dedicated to LC-MS/MS analysis it was 
observed that almost every cell expressed the GFP transgene and MSL3 localization from the 
X-territory in male cells was lost. In this context it has to be assumed that homeostasis of the 
MSL-DCC is highly affected resulting in malfunctioning dosage compensation. These cells 
had been cultivated in roller bottles in order to obtain higher cell numbers. However, in the 
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past these cultivation conditions have been observed to subject cells to stress that also lead to 
high overexpression of the transgene. As a consequence of disrupted MSL stoichiometry cells 
attempt to restore protein homeostasis via attachment of ubiquitin chains and subsequent 
degradation of excess protein through the proteasome. 
We assume that this stress-induced and sex-independent ubiquitylation of high levels of 
ectopic MOF might dominate any low-level MSL2-dependent MOF ubiquitylation. Thus, to 
further determine whether the observed ubiquitylation pattern reflects the accumulation of 
MOF species designated for the proteasome the proteasome machinery was inhibited with 
MG132. Several studies demonstrated that inhibition of the proteasome leads to global 
perturbation of cellular ubiquitylation patterns and increased ubiquitylation of >40% of the 
quantified sites, which mediate proteasome-dependent degradation (Heidelberger, 2016; Kim, 
2011; Wagner, 2011; Udeshi, 2012). Technical limitations however, prevented sufficient 
accumulation of MOF-GFP, which was reflected by the detection of only one single modified 
residue (K715). Notably, this ubiquitylation site was recurrently detected both in in vitro and 
in vivo mass spectrometry approaches employed in this study. 
In summary, the predominating ubiquitylation pattern observed on MOF in vivo most likely is 
independent of dosage compensation and MSL2. Conceivably, MOF might be substrate to 
many different E3 ligases. In turn, this observation does not necessarily imply that 
MSL2-dependent MOF ubiquitylation does not exist. Instead, the contribution of 
MSL2-dependent ubiquitylation in the context of the MSL-DCC may be minute relative to 
abundant bulk MOF ubiquitylation designated for proteasomal turnover and escape detection, 
since the mass spectrometry approach is highly biased towards high abundant peptides. 
 
4.1.2 MOF ubiquitylation - a male-specific role in dosage compensation? 
MSL2 is one of the key components of the MSL-DCC, implicated in the homeostatic control 
of complex stoichiometry and in targeting of substrate protein to the proteasome degradation 
system. The human homolog of MSL2 uses its E3 ubiquitin ligase activity to specifically 
ubiquitylate H2B, a modification involved in the regulation of transcriptional elongation, 
highlighting MSL2-mediated ubiquitylation as a crucial regulatory principle. Likewise, MSL2 
ubiquitylation activity might play additional roles apart from proteasomal targeting in 
Drosophila. 
Initially PLA experiments were performed to answer two questions: (1) Is there a difference 
in the amount of MOF/ubiquitin interaction foci in the nucleus and on the X-territory of cells 
expressing MOF K>R mutants? (2) Is MOF ubiquitylation dependent on MSL2? The first 
question was addressed by analysing selected MOF K>R mutants in cells depleted of 
endogenous MOF. Anti-GFP and anti-ubiquitin antibodies were employed to visualize the 
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interaction of MOF-GFP transgenes and ubiquitin. All MOF mutant cell lines employed in 
this approach exhibited similar numbers of MOF/ubiquitin interaction foci, suggesting that 
the levels of ubiquitylated MOF-GFP were either similar or only very mildly affected in a 
range that can not be distinguished by microscopy anymore (data not shown). Quantification 
of PLA foci on the X-territory in theory is an elegant approach to visualize ubiquitylated 
MOF in context of the MSL-DCC, but unfortunately it was not possible to properly 
discriminate and quantify the amounts of PLA foci on the X-territory. This was mainly due to 
technical limitations, such as inconsistent quality during sample preparation and staining. 
Moreover, the assay might have already been saturated thus not fully resolve increasing 
quantities beyond a certain threshold. 
Addressing the second question it was observed that the numbers of MOF-GFP/ubiquitin 
interaction foci were not affected upon knockdown of MSL2, as already mentioned 
previously. These experiments were optimized by improved sample processing and method 
standardization, and by careful choice of the combination of antibodies (MOF/ubiquitin). Of 
note, it has to be considered that depletion of MSL2 directly affects stability of the MSL-DCC 
and the remaining MOF may therefore exclusively reside in the NSL complex (Lam, 2012) 
and therefore not be related to dosage compensation. Taken together, PLA demonstrated the 
presence of ubiquitylated MOF independent of MSL2 in vivo. The distribution throughout the 
nucleus and cytoplasm points to extensive turnover of MOF and suggests involvement of 
ubiquitylated MOF in several cellular processes apart from dosage compensation. For 
example MOF is also participating in the NSL complex acting on the transcriptional 
regulation of housekeeping genes (Mendjan, 2006; Lam, 2012; Raja, 2010; Feller, 2012). 
Both approaches described above shared one observation: a large pool of ubiquitylated MOF 
was detected not only in nucleus but also in the cytoplasm of Drosophila cells. This 
observation is also supported by unpublished data from the Akhtar laboratory (MPI, Freiburg, 
presentation given at various conferences), showing that human MOF (hMOF) not only 
localizes to the nucleus but also to mitochondria, explaining the cytoplasmatic staining. 
Conceivably, hMOF, in the context of the KANSL2 complex, is involved in regulating 
mitochondrial transcription (Dias, 2014; Chatterjee, 2016). 
Another approach to determine whether MOF ubiquitylation is involved in dosage 
compensation was the analysis of the chromosomal localization of MOF K>R mutants by 
immunofluorescence microscopy. X chromosome targeting and complex association was only 
mildly affected upon expression of N-terminal mutants and MOF-3KC. MOF-9KC is an 
exception to this observation and will be discussed separately. To evaluate whether mild 
effects observed in cells are biologically relevant also in the whole organism, flies lines were 
generated expressing the mutated MOF forms from transgenes. Genetic complementation is 
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the classical approach to assess functionality of given mutants. Here, the male-lethal mof 2 
mutant was employed to assay the functionality of MOF K>R derivatives through their ability 
to rescue the viability phenotype. Whereas immunofluorescence microscopy suggested that 
N-terminal K>R mutants are mildly affected in their X territory targeting and complex 
assembly, in the fly the corresponding N-terminal mutants as well as MOF-3KC 
complemented the male lethality similar to wildtype MOF. These results indicate that the 
K>R mutations within the N-terminus and 3KC indeed only exhibit subtle effects of low 
biological relevance. 
Nevertheless, these complementation experiments provided important principles that have to 
be considered when setting up viability assays in flies. First, the choice of suitable driver lines 
is an essential determinant of the outcome. For example, utilization of the constitutive 
tubulin-GAL4 driver was inappropriate as massive overexpression of the MOF transgenes 
resulted in lethality during pupal stage. On the other hand, employment of the heat shock 
inducible hsp70-GAL4 driver line at normal temperature was insufficient to ensure sufficient 
induction of transgene expression for complementation assays. Instead, employment of the 
armadillo-GAL4 driver provided constitutive transgene expression at a moderate level. 
Second, it was observed that complementation assays rely on functional MOF at early stages 
of development. Thus, a fly line balanced for the mof 2 mutation on the X in combination with 
armadillo-GAL4 driver on the second chromosome was established with the help of Anne 
Classen to maternally deposit wildtype MOF in early stages of embryonic development 
(mof 2/FM7; armadillo-GAL4/ armadillo-GAL4). 
Taken together, mutation of lysines that may be target for MOF ubiquitylation mostly 
displayed only mild effects that did not impair dosage compensation in males. This either 
suggests that MOF ubiquitylation is dispensable for dosage compensation and exclusively 
involved in proteasomal turnover or that the physiological system compensates for the 
relevant deficiencies under these conditions. This is even more remarkable if one considers 
that lysine residues are not only modified by ubiquitylation. Out of all 20 naturally occurring 
amino acids lysine is the residue that is targeted by posttranslational modifications both most 
abundantly and most diversely (Azevedo and Saiardi, 2016): alkylation (methylation, 
butyrylation, propionylation), deamination, succinylation, SUMOylation and acetylation 
amongst others influence the biological properties of a given protein. In particular acetylation 
of lysine residues is known to participate in dynamic regulatory programs by interfering with 
various PTMs and analysis of ubiquitylation sites in U2OS cells revealed that approximately 
20% of ubiquitylated lysine residues are also known to be acetylated (Danielsen, 2011). This 
observation highlights that PTMs not only exhibit complex networks by themselves but also 
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act in extensive competitive crosstalks. It will be interesting to determine whether the lysines 
we identified as potential ubiquitylation sites are also subject to other modifications.  
4.1.3 MOF-9KC mutant exhibits male-specific lethality 
Whereas most of the investigated MOF mutants were only mildly affected in their X territory 
enrichment and complex association, cell lines expressing the C-terminal MOF-9KC mutant 
was dramatically affected in the ability targeting of its GFP-fusion derivative to the X 
chromosome and for impaired complex association. In line with the observations obtained in 
cells, expression of 9KC in flies resulted in reduced male viability. Most likely these defects 
do not result from impaired ubiquitylation but rather from diminished complex association or 
defective HAT activity. 
MOF interaction with the MSL-DCC is achieved via the scaffold protein MSL1, featuring a 
conserved C-terminal PEHE domain that interacts with the zinc finger residing within the 
HAT domain of MOF (Morales, 2004). In human MOF the highly conserved key binding 
residues important for interaction with MSL1 are E199, Y201, Y216, Q261 and F278, which 
correspond to E563, Y565, Y580, Q625 and F642 in Drosophila MOF, respectively (Figure 
37; Kadlec, 2011). Interestingly, 9KC features three point mutations of highly conserved 
lysine residues (K539R, K541R, K545R), which are in steric proximity to the residues crucial 
for MOF/MSL1 interaction and might affect electrostatic properties of the HAT domain 
resulting in diminished interaction with MSL1. 
In order to address functional consequences of K>R mutations and of 9KC in particular, the 
HAT activity of recombinant MOF on free histones and nucleosomal histones was monitored. 
MOF wt, MOF-9KN and ΔN mutants share one common feature: they all exhibited similar 
acetylation activity on free H4 histone proteins. This observation can be attributed to the 
presence of a wildtype HAT domain. At the same time introduction of K>R point mutations 
into the N-terminus (9KN) did not change substrate specificity and enzymatic activity 
towards free histones. 
Many members of the MYST HAT family have been described to exhibit full enzymatic 
activity and specificity only in the background of their native complexes. For example, TIP60 
readily acetylates free histones but fails to modify histone-containing polynucleosomes unless 
it is incorporated into the TIP60 complex (Ikura, 2000). Similar, MOF alone is able to 
actetylate free H4, yet acetylation of H4 in a nucleosomal context requires association of 
MOF with MSL1-MSL3 (Morales, 2004). In the absence of MSL3 MOF exhibits acetylation 
activity primarily towards MSL1 even in the presence of a nucleosomal substrate, 
highlighting that interaction of MOF with the MSL-DCC directly affects substrate specificity. 
Interestingly, not only faithful complex assembly but also the MOF N-terminus itself was 
suggested to be involved in the autoregulation of HAT activity (Conrad, 2012). 
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Figure 37: The MSL1-MOF subcomplex - structure and sequence alignment. (A). Crystal structure 
of the human MSL1-MOF subcomplex displayed as ribbon diagram. MOF HAT domain is shown in blue, 
acetyl-CoA bound to the HAT domain is shown in yellow, MSL1 fragment is shown in red. [Adapted and 
reprinted with permission (Kadlec, 2011; NSMB).] (B) Sequence alignment of Drosophila and human 
MOF HAT domain. Numbers indicate amino acid positions of key binding residues in MOF required for 
MSL1 binding. MOF zinc finger is highlighted by grey background color (aa 575-592). Conserved lysine 
residues between Drosophila and human MOF are shown in green. 
 
Analysis of MOF mutants in the presence of the MSL1-MSL3 subcomplex on nucleosomal 
histones further confirmed that MOF-9KN is not impaired in HAT activity. Moreover, 9KC 
exhibited acetylation activity similar to MOF wt and 9KN, in contrast to 3KC, which 
displayed changes in substrate specificity. These results appear not intuitive: why should the 
mutant with more K>R mutations be less affected in enzymatic activity than the one with 
fewer mutations? MOF-3KC still interacts with the MSL-DCC and insertion of mutations 
within the HAT domain might change substrate specificity and perturb enzymatic activity as 
seen by increased acetylation of H4 and MSL1, but also increased autoacetylation on MOF. 
In turn, 9KC might still possess hyperactive enzyme activity, however might be covered by 
the fact that 9KC does not interact with the MSL-DCC thus cannot exhibit acetylation activity 
on MSL1. 
Taken together these results suggest that interference with the N-terminal lysine residues does 
not influence HAT activity, while on the other side introduction of C-terminal mutations close 
to the enzymatic domain affect substrate specificity and enzymatic activity. 
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4.1.4 Possible functions of MOF ubiquitylation 
To recapitulate the functions of ubiquitylation it is not only crucial to study the functions of 
ubiquitylated substrates per se but also to identify respective writer enzymes. In Drosophila 
MOF is modified by the E3 RING ligase MSL2, however it has to be assumed that MOF is 
also substrate to other E3 RING ligases. 
RING finger-containing E3 ligases are characterized by a reaction mechanism in which the 
ubiquitin ligase binds both E2 and substrate to ensure proximity for efficient and direct 
transfer of the activated ubiquitin from E2 to the substrate (Özkan, 2005). However, E3 
ligases also interact with substrates by indirect means via an interaction partner (Buetow and 
Huang, 2016; Mizushima, 2007). For example, in the context of DNA damage and repair, the 
E3 CRL-DDB complex recognizes UV-induced pyrimidine dimer lesions on DNA where 
CRL-DDB ubiquitylates associated XPC and DDB2 to trigger nucleotide excision repair 
(Scrima, 2008; El-Mahd, 2006; Sugasawa, 2005). Furthermore, some E3 ligases recognize 
certain domains or binding motifs that enable site-specific targeting to sites of action where 
E3 ligases exhibit enzymatic activity on any substrate available. So far MOF and MSL2 were 
never shown to directly interact with each other. Instead it is assumed that MSL1 provides a 
scaffold for the interaction of MSL2 and MOF (Hallacli, 2012; Morales, 2004; Scott, 2000). 
Even though E3 ligases are reportedly introduced as proteins with high substrate specificity 
some E3 ligases exhibit a rather promiscuous reaction profile not only with respect to the 
target residues within a particular substrate but also regarding the substrate in general. In in 
vitro ubiquitylation assays both MSL2 and Mdm2 were able to modify MOF. Considering 
that about 150 E3 ligases exist in Drosophila (Du, 2011) MOF may also be substrate to other 
E3 ligases, which complicates the analysis of MSL2-dependent MOF ubiquitylation in vivo. 
While it remains unclear, whether MSL-2 dependent MOF ubiquitylation exists at all, the 
observed ubiquitylation pattern on MOF in vitro clearly demonstrated that N-terminal 
ubiquitylation is possible. Still the question remains: why is N-terminal ubiquitylation never 
detected in vivo? 
One possible explanation for this phenomenon could be a rapid turnover of N-terminally 
ubiquitylated MOF species in vivo. PEST motifs (proline, glutamic acid, serine and threonine) 
mediate ubiquitylation, induce subsequent degradation and point to rapid turnover of target 
protein (Marchal, 1998) thus might be involved in the clearance of N-terminally ubiquitylated 
MOF. Indeed, the MOF N-terminus exhibits several such motifs whereas for the C-terminus 
no such motifs were predicted (Figure 38). On the other hand, N-terminal ubiquitylation 
might occur at very low levels only and be dominated by C-terminal modification that 
represents bulk cellular MOF ubiquitylation outside of the MSL-DCC. 
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Figure 38: Functions of MOF ubiquitylation. MOF exhibits N-terminal PEST-motifs. Motif prediction of 
MOF protein sequence reveals PEST motifs, indicated by asterisks. Ubiquitylated lysine residues after 
MSL2 in vitro ubiquitylation are highlighted in yellow, modified lysines found by ubiquitylome analysis 
are underscored and highlighted in yellow. Numbers indicate aa positions. Unstructured MOF N-
terminus (aa 1-350).  
 
Another explanation might be attributed to a specialized role of N-terminal MOF 
ubiquitylation in the context of dosage compensation. MSL2-dependent modification of MOF 
within the N-terminus might reflect only a small proportion of total MOF ubiquitylation. One 
hypothesis poses that ubiquitylation of MOF serves as a checkpoint to target wrong protein 
assemblies for degradation. Accordingly, MOF-MSL2 interactions that occur off the X 
chromosome may be eliminated and not be detectable. Following this line of argument, 
regular MSL2-MOF complexes assembled at the X chromosomal HAS may be stable. In such 
a scenario, the N-terminus of MOF may be stably engaged in protein interactions in the 
context of the MSL-DCC, which may occlude access of any E3 ligase. In vitro ubiquitylation 
assays performed in the presence of DNA support this hypothesis as loss of MOF 
ubiquitylation was observed after addition of DNA to the ubiquitylation reaction. Despite 
many lines of evidence and different experimental setups to approach MOF ubiquitylation, it 
remains elusive whether ubiquitylated MOF is involved in functions apart from proteasomal 
targeting. 
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4.1.5 Conclusions and future perspectives on MOF ubiquitylation  
Despite multiple many efforts and various assays employed both in vitro and in vivo functions 
of MOF ubiquitylation remain elusive. In general, the genetic complementation analyses of 
mutated transgenes offers a powerful tool to study the biological functions of a given protein 
in vivo. Similar approaches have been successfully employed for the analysis of MSL2-GFP 
and MLE-GFP in the Becker laboratory before. In contrast to MOF, the in vitro ubiquitylation 
sites of MLE were nicely recapitulated also on MLE-GFP in vivo (unpublished data, R. 
Villa). Observed discrepancies between in vitro and in vivo data might be explained by the 
different molecular context of transgenic and endogenous MOF. In a theoretical scenario the 
two MOF species could either compete with each other or, in an extreme case, MOF-GFP 
will not be incorporated into the MSL-DCC at all. MOF, in contrast to the other MSL-DCC 
proteins, is involved in cellular processes apart from dosage compensation. Thus it is likely 
that a fraction of expressed MOF-GFP will associate with the NSL complex to fulfill different 
tasks. Moreover, the fraction of MOF-GFP observed in the cytoplasm accounts for a big 
proportion of neither MSL-DCC or NSL-related MOF. Accordingly, the ubiquitylated MOF-
GFP species detected by mass spectrometry represent a combination of both nuclear and 
cytoplasmic protein of diverse physiological context and function. Hence, employment of 
refined experimental setups on endogenous protein might be more suitable in this context. In 
general, two central steps can be improved: (1) affinity purification of ubiquitylated proteins 
and (2) enrichment of ubiquitin remnants using suitable di-glycine antibodies followed by 
peptide fractionation (Porras-Yakushi and Hess, 2014). Moreover, coupling proteome-wide 
ubiquitin remnant profiling to metabolic labeling of endogenous MOF in a SILAC approach 
allows the quantification of relative abundance of ubiquitylation sites. Such an experiment is 
currently being performed in male and female cells and might reveal male-specific MSL2-
related MOF ubiquitylation sites in vivo as well as confirm the MOF ubiquitylation sites 
obtained from the S2 ubiquitylome. In addition, application of ubiquitin remnant profiling 
using di-glycine enrichment of wildtype, endogenous MOF after proteasome inhibition offers 
an alternative perspective for follow up experiments. The di-glycine enrichment requires less 
cell material, allowing MG132 treatment at smaller scales, where sufficient endogenous MOF 
accumulates. 
An approach to specifically study the impact of MOF ubiquitylation may be provided by the 
SpyCatcher system, a methodology that uses the principles of peptide tagging (Zakeri, 2012; 
Li, 2014). Usually interactions of proteins with peptides are unstable and rapidly reversible. 
The SpyCatcher system in turn is characterized by a rapid and irreversible formation of an 
isopeptide linkage between Spy-tag and SpyCatcher. The Spy-tag consists of 13 amino acids 
able to form a covalent bond to its protein partner (SpyCatcher, 138 amino acids, 15 kDa). A 
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scenario where the Spy-tag is integrated into MOF and the SpyCatcher is linked to an 
ubiquitin moiety may enable the construction of a branched protein mimicking the site-
specific mono-ubiquitylation of MOF with high efficiency. Such ubiquitylated MOF species 
might be generated with high homogeneity and thus may be subjected to HAT assays, MSL1 
interaction studies and nucleosome binding assays to characterize the impact of site-specific 
ubiquitylation. In an attempt to follow this approach Spy-tagged MOF versions were 
established as well as a SpyCatcher linked to a mono-ubiquitin moiety. However, expression 
and purification of recombinant protein was insufficient and will need further optimizations. 
Finally, employment of a functional MOF mutant that cannot be incorporated into the 
NSL-complex and therefore exclusively resides in the MSL-DCC might be further explored 
to avoid analyzing the NSL-related MOF fraction. 
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4.2. SPT6, a target for MSL2-mediated ubiquitylation? 
Many studies have highlighted the role of transcriptional elongation in the mechanism of 
dosage compensation to mediate upregulation of X-linked genes in Drosophila males (Ferrari, 
2013; Larschan, 2011; Prabhakaran and Kelley, 2012; Regnard, 2011; Straub and Becker, 
2007). The identification of SPT6 as a putative substrate for MSL2-dependent ubiquitylation 
raised the possibility that such modification of SPT6 is implicated in the regulation of 
elongation (Ardehali, 2009; Dronamraju and Strahl, 2014). To prepare future studies on SPT6 
in vitro and in vivo, recombinant protein, stable cell lines and monoclonal antibodies directed 
against SPT6 were established. The antibodies were highly specific in Western blot and 
immunofluorescence microscopy. Moreover, first results indicated that in vitro SPT6 is 
ubiquitylated by MSL2. 
The mechanism of twofold upregulation of X-linked genes in Drosophila dosage 
compensation is mechanistically linked to transcriptional elongation (Larschan, 2011; 
Prabhakaran and Kelley, 2012; Ferrari, 2013; Kuroda, 2016). Still, the implications of SPT6 
in the context of dosage compensation haven’t been studied so far. The observation that 
MSL2 is able to ubiquitylate SPT6 in vitro might provide a link for its involvement in the 
regulation of dosage compensation. The experimental approaches to address this question will 
rely on an elaborate study design because SPT6 is critically involved in many functions 
outside of dosage compensation that must be differentiated from its potential effect on X 
chromosomal genes. 
SPT6 is a well-studied histone H3-H4 chaperone associated with elongating RNAPII in yeast, 
flies and humans (Andrulis, 2000; Kaplan, 2000; Yoh, 2007). It acts as a multifunctional 
regulator of transcription and epigenetic modification of chromatin. For example, SPT6 also 
associates with the H2A-H2B histone chaperone FACT to coordinate disassembly and 
reassembly of nucleosomes during gene transcription (Belotserkovskaya 2003; Saunders, 
2003). Moreover, Drosophila SPT6 was implicated in the turnover of improperly processed 
pre-mRNAs through the exosome machinery, a complex of 3’-5’ exonucleases (Andrulis, 
2002). SPT6 is further involved in the Set2-dependent positioning of H3K36me3, a histone 
mark found in regions of active transcription (Youdell, 2008). In contrast, SPT6 negatively 
regulates H3K27me3, which marks polycomb-repressed gene regions (Kato, 2013). Recent 
studies have linked yeast SPT6 to the control of H4K16ac levels by deposition of K16-
unacetylated H4 into strongly transcribed genes (Reiter, 2015). 
The experience gained from difficulties of the analysis of MOF ubiquitylation highlighted the 
complexity and challenges in this research field and precluded addressing the more difficult 
question of a role for SPT6 ubiquitylation in X-chromosome-specific regulation. 
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4.3 The analysis of ubiquitylation- limitations and challenges 
Since the pioneering experiments of Peng et al. proteomic ubiquitylome analyses have 
provided a wealth of data on the role of ubiquitylation, novel ubiquitylation targets as well as 
their involvement in the regulation of biological pathways (Peng, 2003; Porras-Yakushi and 
Hess, 2014). The rapid development of mass spectrometry-based proteomics in combination 
with classical molecular biology methods (site-directed mutagenesis), biochemical assays (in 
vitro ubiquitylation assays) and investigation of biological systems allows unraveling the 
complexity of the ubiquitin network. Yet, the field of ubiquitylation faces major challenges 
and limitations. 
First of all, numerous types of ubiquitin modifications are present in vivo and it is not always 
clearly defined which modification exactly translates which biological role. Due to the 
manifold potential to create ubiquitin chains varying not only in length of attached ubiquitin 
moieties but also in type of linkages exhibited, ubiquitylation is a very complex modification 
with manifold functions and biological consequences. On a historical basis cellular functions 
of protein ubiquitylation were separated into proteolytic functions marked by Lys48-linked 
ubiquitin chains and non-proteolytic functions represented by Lys63-linked chains. Lys48-
linked chains are still most abundantly found in all organisms and rapidly accumulate upon 
inhibition of the proteasome (Peng, 2003; Xu, 2009; Kim et al., 2011). However, today this 
view appears too simplistic. For example, it is now clear that Lys63-linked chains are able to 
transmit degradation and Lys48-linked chains also act on the regulation of transcription 
factors (Flick, 2006; Kaiser, 2000). Hence, the current view on deciphering the ubiquitin code 
suggest that chain topology rather than individual ubiquitin linkages translate the functions 
and consequences of ubiquitylation (Swatek and Komander, 2016). The separation of 
biological consequences of ubiquitin attachment into proteolytic and non-proteolytic 
functions in general is still valid in a way that ubiquitin might either regulate proteasomal and 
lysosomal degradation, respectively, or as examples for non-proteolytic function, acts on the 
regulation of protein interactions, protein localization and protein activity (Komander and 
Rape, 2012). 
Importantly, ubiquitin is not only substrate for ubiquitylation itself but the interdependency 
and crosstalk between ubiquitin and other PTMs adds another layer of complexity to the 
ubiquitin signaling network (Swaney, 2013; Wu, 2011). Another challenge in studying 
protein ubiquitylation is the usually rapid turnover of proteins modified for degradation by the 
proteasomal machinery. In addition, deubiquitylating enzymes (DUBs) further contribute to 
low steady state levels of protein ubiquitylation. 
State of the art techniques in the ubiquitylation field focus on two major approaches: 
biochemical methods for the analysis of ubiquitin chain architecture and mass spectrometry- 
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based approaches. The first approach either utilizes specific ubiquitin-binding proteins that 
recognize certain polyubiquitin chains with high affinity (Sims, 2012; van Wijk, 2012) or 
employ DUBs on endogenous proteins to visualize ubiquitin linkage type in a PAGE-based 
assay (UbiCRest; Hospenthal, 2015). UbiCRest is based on the linkage preference of the 
employed DUB, e.g. for Lys48 or Lys63-specific ubiquitin linkages. Electrophoretic 
mobilities of the obtained ubiquitin cleavage products after DUB treatment reveal ubiquitin 
linkages originating from the protein of interest. Mass spectrometry-based methods on the 
other hand still provide the most important tools for the detection of ubiquitylated peptides. 
Despite the constant improvements in data analysis, purification methods as well as technical 
advance in detecting ubiquitylated peptides still faces some critical limitations: LC-MS/MS is 
biased towards highly abundant ubiquitylated species, thus not all modified peptides resulting 
from trypsin digestion of the cellular proteome will be detected. Moreover, it has to be 
considered that analysis and quantification of ubiquitylomics using mass spectrometry is still 
highly affected by experimental variation. Both sample preparation as well as the mass 
spectrometry analysis itself might introduce errors. Whereas errors in sample preparation can 
be limited by co-preparation of technical replicates within a particular set of experiments, 
errors in mass spectrometry analysis are caused by the instrument itself (Heidelberger, 2016). 
The classical workflow of isolating the sample of interest, digestion into peptides, followed 
by chromatographic peptide separation and finally mass spectrometry can be optimized by 
combination of both enrichment and labeling strategies. Isolation of the protein of interest 
from distinct cellular organelles, enrichment by protein or protein tag-specific antibodies and 
well as enrichment via the PTMs already narrow down the input material for shotgun 
proteomics. Finally, generation of quantitative data involves the labeling of cells (SILAC) or 
peptides (TMT, tandem mass tags) and the utilization of labeled proteins or peptide standards 
(Ordureau, 2015). 
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aa   Amino acid 
ac   Acetylation 
ADP   Adenosine diphosphate 
Amp   Ampicillin 
ATP    Adenosine triphosphate 
BLAST   Basic Local Alignment Search Tool 
bp   Base pair 
BSA   Bovine serum albumin 
°C   Degree Celsius 
CBD   Chromobarrel domain 
cDNA   complementary DNA 
CES   Chromatin entry site 
ctrl   Control  
DAPI    4',6-diamidino-2-phenylindole 
DCC   Dosage compensation complex 
DGRC   Drosophila Genomics Resource Center 
DNA   Deoxyribonucleic acid 
dsRNA   Double stranded RNA 
E1   Ubiquitin-activating enzyme E1 
E2   Ubiquitin-conjugating enzyme E2 
E3   Ubiquitin protein ligase E3 
fw   forward 
Gal4   Yeast transcription activator protein GAL4 
GFP   Green fluorescent protein 
gp   guinea pig 
H2B   Histone 2B 
H4   Histone 4 
HAS   High affinity site 
HAT   Histone acetyltransferase 
HDAC   Histone deacetylase 
I   Input 
IF   Immunofluorescence 
IP   Immunoprecipitation 
K   Lysine 
Kan   Kanamycin 
Kc   Drosophila cell line, female karyotype 
kDa   Kilodalton 
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LC-MS/MS  Liquid chromatography–mass spectrometry/ mass spectrometry 
L2-4   Drosophila Schneider cells, S2 clone, male karyotype 
mA   Milliampere 
Mdm2    Mouse double minute 2  
me   Methylation 
MLE   Maleless 
MOF   Males-absent-On-the-First 
mRNA   Messenger RNA 
MRE   MSL recognition element 
ms   mouse 
MSL   Male-Specific-Lethal 
NDS   Normal donkey serum 
NGS   Normal goat serum 
NSL   Non-specific lethal 
P   Pellet 
PBS   Phosphate buffered saline 
PCR   Polymerase chain reaction 
PionX   Pioneering sites on the X  
PMSF   Phenylmethanesulfonyl fluoride 
PTM   Posttranslational modification 
rb   rabbit 
RING   Really interesting new gene 
RNA   Ribonucleic acid 
RNAi   RNA interference 
RNAPII  RNA polymerase II 
rpm   Revoltations per minute 
rox   RNA-on-the-X 
RT   Room temperatture 
S/N   Superatant 
S2   Drosophila Schneider cells, male karyotype 
SDS-PAGE  Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
Sf21   Spodoptera frugiperda 21 
Sgs3   Salivary gland secretion 3 
SILAC   Stable isotope labeling by amino acids in cell culture 
siRNA   small interfering RNA 
SPT6   Suppressor of Ty 6; Transcription elongation factor 
SXL   Sex lethal  
5 ABBREVIATIONS 
108 
PFA   para-Formaldehyde 
PLA   Proximity ligation assay 
rv   Reverse 
UAS   Upstream activating sequence 
Ub   Ubiquitin 
UTR   Untranslated region 
v/v   Volume per volume 
WB   Western blot 
wt   Wild type 
w/v   Weight per volume 
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